epocrates logo
epocrates logo
epocrates logo
  • 0

Drugs


Formulary
No Formulary Selected

Classes

  • All Drugs
  • Allergy/Cold/ENT
  • Anesthesia/Pain Management
  • Asthma/Pulmonary
  • Cardiovascular
  • Dental/Oral Care
  • Dermatologic
  • Diagnostic
  • Emergency
  • Endocrine/Metabolism
  • Gastrointestinal
  • Hematology/Oncology
  • Immunizations
  • Immunology
  • Infectious Disease
  • Nephrology/Urology
  • Neurologic
  • Nutrition/Electrolytes
  • Obstetrics/Gynecology
  • Ophthalmic
  • Psychiatric
  • Rheumatologic

Drug Names

# A B C D E F G H  I  J K L M N O P Q R S T U V W X Y Z
A+D Anti-Chafing Ointment
A+D Diaper Rash Cream
A+D First Aid Ointment
A+D Incontinence Support Skin Protectant & Rash Ointment
A+D Medicated Rash Ointment
A+D Original Ointment
A+D Overnight Healing Rash Ointment
abacavir
abacavir/dolutegravir/lamivudine
abacavir/lamivudine
abacavir/lamivudine/zidovudine
abaloparatide
abametapir topical
abatacept
Abecma
Abelcet
abemaciclib
Abigale
Abigale Lo
Abilify
Abilify Asimtufii
Abilify Discmelt
Abilify Maintena
Abilify MyCite
abiraterone acetate
abiraterone acetate micronized
Ablysinol
abobotulinumtoxinA
Abraxane
Abreva
Abreva Rapid Pain Relief
Abrilada (adalimumab-afzb)
abrocitinib
Abrysvo
Absorica
Absorica LD
Abstral
acalabrutinib
ACAM2000
acamprosate
Acanya
acarbose
Accolate
Accrufer
AccuNeb
Accupril
Accuretic
Accutane
acebutolol
aceclidine ophthalmic
Aceon
Acetadote
acetaminophen
acetaminophen rectal
acetaminophen/aspirin
acetaminophen/aspirin/caffeine
acetaminophen/aspirin/diphenhydramine
acetaminophen/caffeine
acetaminophen/caffeine/dihydrocodeine
acetaminophen/caffeine/pyrilamine
acetaminophen/chlorpheniramine
acetaminophen/chlorpheniramine/dextromethorphan
acetaminophen/chlorpheniramine/dextromethorphan/phenylephrine
acetaminophen/chlorpheniramine/dextromethorphan/pseudoephedrine
acetaminophen/chlorpheniramine/phenylephrine
acetaminophen/codeine
acetaminophen/dextromethorphan
acetaminophen/dextromethorphan/guaifenesin
acetaminophen/dextromethorphan/phenylephrine
acetaminophen/dextromethorphan/phenylephrine/guaifenesin
acetaminophen/dextromethorphan/pseudoephedrine
acetaminophen/diphenhydramine
acetaminophen/diphenhydramine/phenylephrine
acetaminophen/doxylamine/dextromethorphan
acetaminophen/doxylamine/dextromethorphan/phenylephrine
acetaminophen/guaifenesin
acetaminophen/ibuprofen
acetaminophen/pamabrom
acetaminophen/pamabrom/pyrilamine
acetaminophen/phenylephrine
acetaminophen/phenylephrine/guaifenesin
acetaminophen/pseudoephedrine
acetaminophen/triprolidine/dextromethorphan
acetaminophen/triprolidine/dextromethorphan/phenylephrine
acetazolamide
acetic acid otic
acetohydroxamic acid
acetylcholine intraocular
acetylcysteine
Aciphex
Aciphex Sprinkle
acitretin
aclidinium bromide inhaled
aclidinium bromide/formoterol inhaled
Aclovate
acoltremon ophthalmic
acoramidis
acrivastine/pseudoephedrine
Actemra
Acthar Gel
ActHIB
Acticlate
Actidose with Sorbitol
Actidose-Aqua
Actigall
Actimmune
Actiq
Activase
Activella
Actonel
Actonel with Calcium
ACTOplus met
ACTOplus met XR
Actos
Acular
Acular LS
Acuvail
Acuvue Theravision with Ketotifen
acyclovir
acyclovir oropharyngeal
acyclovir topical
acyclovir/hydrocortisone topical
Aczone
Adacel
adagrasib
Adakveo (crizanlizumab-tmca)
Adalat CC
adalimumab
ADAMTS13, recombinant
adapalene topical
adapalene/benzoyl peroxide topical
Adasuve
Adbry (tralokinumab-ldrm)
Adcetris
Adcirca
Adderall
Adderall XR
Addyi
adefovir dipivoxil
Adempas
Adenocard
Adenoscan
adenosine
adenovirus type 4 and type 7 vaccine, live oral
Adhansia XR
Adipex-P
Adlarity
Adlyxin
Admelog
ado-trastuzumab emtansine
Adoxa
Adquey
Adrenaclick
Adrenalin
Adriamycin
Adrucil
Adstiladrin (nadofaragene firadenovec-vncg)
aducanumab
Aduhelm (aducanumab-avwa)
Advair Diskus
Advair HFA
Advate
Advil
Advil Allergy & Congestion Relief
Advil Allergy Sinus
Advil Cold & Sinus
Advil Dual Action with Acetaminophen
Advil Dual Action with Acetaminophen Back Pain
Advil Migraine
Advil Multi-Symptom Cold & Flu
Advil PM
Advil Sinus Congestion & Pain
Advil Targeted Relief Cream
Adynovate
Adzenys ER
Adzenys XR-ODT
Adzynma (ADAMTS13, recombinant-krhn)
Aemcolo
afamelanotide
afamitresgene autoleucel
afatinib
Afeditab CR
aficamten
Afinitor
Afinitor Disperz
aflibercept intravitreal
Afluria
Afrezza
Afrin Allergy Sinus
Afrin No Drip Allergy Sinus
Afrin No Drip Allergy Sinus Night
Afrin No Drip Extra Moisturizing
Afrin No Drip Night
Afrin No Drip Original
Afrin No Drip Severe Congestion
Afrin Original
Afrin Severe Congestion
Afstyla
agalsidase beta
Agamree
Aggrastat
Aggrenox
Agrylin
Ahzantive (aflibercept-mrbb)
Aimovig (erenumab-aooe)
air polymer-type A
AirDuo Digihaler
AirDuo RespiClick
Airsupra
Ajovy (fremanezumab-vfrm)
AK-Dilate
AK-Poly-Bac
Akeega
Aklief
Akne-mycin
Akovaz
Akten
Aktipak
Akynzeo
Akynzeo IV
Ala-hist IR
Alahist CF
Alahist D
Alahist DM
Alahist PE
Alamast
Alavert
Alavert D-12 Hour
Alaway
albendazole
Albenza
albiglutide
Albuked
albumin (human)
Albuminar
Albuminex (albumin (human)-kjda)
AlbuRx
Albutein
albuterol
albuterol inhaled
albuterol/budesonide inhaled
alcaftadine ophthalmic
Alcaine
alclometasone topical
Aldactazide
Aldactone
Aldara
aldesleukin
Aldomet
Aldurazyme
Alecensa
alectinib
alemtuzumab
alendronate
alendronate/cholecalciferol
Alesse
Aleve
Aleve Arthritis Pain Gel
Aleve Back & Muscle Pain
Aleve Headache Pain
Aleve PM
Aleve-D Sinus & Cold
AleveX Lotion
AleveX Spray
Alfenta
alfentanil
alfuzosin
alglucosidase alfa
Alhemo (concizumab-mtci)
Alimta
Alinia
Aliqopa
alirocumab
aliskiren
aliskiren/hydrochlorothiazide
alitretinoin topical
Alka-Seltzer Cool Action Heartburn Relief Gum
Alka-Seltzer Extra Strength Heartburn ReliefChews
Alka-Seltzer Extra Strength Upset Stomach Relief
Alka-Seltzer Hangover Relief
Alka-Seltzer Heartburn + Gas ReliefChews
Alka-Seltzer Original
Alka-Seltzer Plus Cold & Flu FizzyChews
Alka-Seltzer Plus Cough & Sore Throat FizzyChews
Alka-Seltzer Plus Maximum Strength Cold & Cough
Alka-Seltzer Plus Maximum Strength Cold & Cough PowerMax
Alka-Seltzer Plus Maximum Strength Cold & Flu Day
Alka-Seltzer Plus Maximum Strength Cold & Flu Day PowerMax
Alka-Seltzer Plus Maximum Strength Cold & Flu Night
Alka-Seltzer Plus Maximum Strength Cold & Flu Night PowerMax
Alka-Seltzer Plus Maximum Strength Cough & Chest Congestion Power...
Alka-Seltzer Plus Maximum Strength Cough, Mucus & Congestion Powe...
Alka-Seltzer Plus Maximum Strength Cough, Mucus & Congestion Powe...
Alka-Seltzer Plus Maximum Strength Sinus Congestion & Pain PowerF...
Alka-Seltzer Plus Maximum Strength Sinus Congestion & Pain PowerM...
Alka-Seltzer Plus Maximum Strength Sinus, Allergy & Cough PowerMa...
Alka-Seltzer Plus Severe Cold & Cough PowerFast Fizz
Alka-Seltzer Plus Severe Cold & Flu Day
Alka-Seltzer Plus Severe Cold & Flu Night
Alka-Seltzer Plus Severe Cold & Flu PowerFast Fizz
Alka-Seltzer Plus Severe Cold PowerFast Fizz
Alka-Seltzer Plus Severe Cold PowerFast Fizz Night
Alka-Seltzer Plus Severe Cold PowerFast Fizz Non-Drowsy
Alka-Seltzer Plus Severe Sinus, Cold & Cough
Alka-Seltzer Upset Stomach Relief
Alkeran
Alkindi Sprinkle
Allegra Allergy 12 Hour
Allegra Allergy 24 Hour
Allegra Hives 24 Hour
Allegra-D 12 Hour Allergy & Congestion
Allegra-D 24 Hour Allergy & Congestion
Aller-chlor
Alli
allogeneic cell therapy
allopurinol
Allzital
almotriptan
Alocril
alogliptin
alogliptin/metformin
alogliptin/pioglitazone
Alomide
Aloprim
Alora
alosetron
Aloxi
alpelisib
alpha-tocopherol (vitamin E)
alpha1-proteinase inhibitor
Alphagan P
Alphanate
alprazolam
Alprolix
alprostadil
alprostadil intracavernous
alprostadil intraurethral
Alrex
Alsuma
Altabax
Altace
Altafluor Benox
Altavera
alteplase
alteplase intracatheter
Altoprev
Altreno
Altuviiio (antihemophilic factor (recombinant), Fc-VWF-XTEN fusio...
aluminum acetate topical (modified Burow's solution)
aluminum chloride topical
aluminum hydroxide
aluminum hydroxide/magnesium carbonate
aluminum hydroxide/magnesium hydroxide
aluminum hydroxide/magnesium hydroxide/simethicone
Alunbrig
Alvaiz
Alvesco
alvimopan
Alyacen 1/35
Alyacen 7/7/7
Alyftrek
Alyglo (immune globulin human-stwk)
Alymsys (bevacizumab-maly)
Alyq
Amabelz
amantadine
Amaryl
Ambien
Ambien CR
AmBisome
ambrisentan
amcinonide topical
Ameluz
Amerge
Amethia
Amethia Lo
Amethyst
Amicar
Amidate
amifampridine
amifostine
amikacin
amikacin liposomal inhaled
Amikin
amiloride
amiloride/hydrochlorothiazide
aminocaproic acid
aminolevulinic acid topical
aminophylline
amiodarone
amisulpride
Amitiza
amitriptyline
amivantamab
amivantamab/hyaluronidase
Amjevita (adalimumab-atto)
amlodipine
amlodipine/atorvastatin
amlodipine/benazepril
amlodipine/celecoxib
amlodipine/olmesartan medoxomil
amlodipine/valsartan
amlodipine/valsartan/hydrochlorothiazide
ammonium lactate topical
Ammonul
Amnesteem
Amondys 45
amoxapine
amoxicillin
amoxicillin/clavulanate
Amoxil
Amphadase
amphetamine
Amphocin
Amphojel
Amphotec
amphotericin B cholesteryl sulfate
amphotericin B deoxycholate
amphotericin B lipid complex
amphotericin B liposomal
ampicillin
ampicillin/sulbactam
Ampyra
Amrix
Amtagvi
Amvuttra
amyl nitrite/sodium nitrite/sodium thiosulfate
Amzeeq
anacaulase topical
Anacin
Anafranil
anagrelide
anakinra
Analpram E
Analpram HC
AnaMantle HC
Anaphylm
Anaprox
Anaprox DS
Anascorp
Anaspaz
anastrozole
Anavip
Anbesol Maximum Strength
Ancef
Ancobon
Andembry (garadacimab-gxii)
Andexxa (coagulation factor Xa (recombinant), inactivated-zhzo)
Androderm
AndroGel
Android
Androxy
Anectine
Angeliq
Angiomax
Angiomax RTU
angiotensin II
anidulafungin
anifrolumab
Anjeso
Anktiva (nogapendekin alfa inbakicept-pmln)
Annovera
Anoro Ellipta
Ansaid
ansuvimab
Antabuse
Antara
Anthim
Anthrasil
anthrax immune globulin (human)
anthrax vaccine
anthrax vaccine, adjuvanted
anti-inhibitor coagulant complex
anti-thymocyte globulin (rabbit)
antihemophilic factor (factor VIII, human)
antihemophilic factor (factor VIII, human)/von Willebrand factor ...
antihemophilic factor (factor VIII, recombinant)
antihemophilic factor (factor VIII, recombinant), Fc fusion prote...
antihemophilic factor (factor VIII, recombinant), glycopegylated
antihemophilic factor (factor VIII, recombinant), pegylated
antihemophilic factor (factor VIII, recombinant), porcine
antihemophilic factor (factor VIII, recombinant), single chain
antihemophilic factor (recombinant), Fc-VWF-XTEN fusion protein
antipyrine/benzocaine otic
antithrombin (recombinant)
antithrombin III
Antivert
Antizol
Anucort-HC
Anusol-HC Cream
Anusol-HC Suppository
Anzupgo
Apadaz
apalutamide
ApexiCon
ApexiCon E
Aphexda
Apidra
apitegromab
Apitegromab
apixaban
Aplenzin
Aplisol
Apokyn
apomorphine
Aponvie
apraclonidine ophthalmic
apremilast
aprepitant
Apresoline
Apretude
Apri
Apriso
aprocitentan
Aptensio XR
Aptiom
Aptivus
Aqneursa
Aquaphor
Aquaphor Baby Diaper Rash
Aquaphor Itch Relief
Aquasol A
Aquasol E
Aqvesme
Arakoda
Aralast NP
Aralen
Aranelle
Aranesp
Arava
Arazlo
Arbinoxa
Arbli
Arcalyst
Aredia
Arepanrix
Arexvy
arformoterol inhaled
argatroban
arginine
Aricept
Aricept ODT
Arikayce
Arimidex
arimoclomol
aripiprazole
aripiprazole bimonthly injection
aripiprazole lauroxil
aripiprazole monthly injection
Aristada
Aristada Initio
Arixtra
Armlupeg (pegfilgrastim-unne)
armodafinil
ArmonAir Digihaler
ArmonAir RespiClick
Armour Thyroid
Arnuity Ellipta
Aromasin
Arranon
arsenic trioxide
Artane
artemether/lumefantrine
artesunate
Arthriten
Arthritis Hot
Arthrotec
articaine/epinephrine
Arymo ER
Arynta
Arzerra
Asacol
Asacol HD
Asceniv (immune globulin human-slra)
asciminib
Ascor
ascorbic acid (vitamin C)
asenapine
asenapine transdermal
asfotase alfa
Ashlyna
Asmanex HFA
Asmanex Twisthaler
asparaginase
asparaginase Erwinia chrysanthemi
asparaginase erwinia chrysanthemi (recombinant)
Asparlas (calaspargase pegol-mknl)
Aspercreme
Aspercreme Arthritis Pain
Aspercreme Lidocaine 3 in 1 Foot Pain Relief Cream
Aspercreme Lidocaine Foot Pain Cream for Diabetic Skin
Aspercreme Lidocaine Pain Relief Cream
Aspercreme Lidocaine Pain Relief Liquid Roll-On
Aspercreme Lidocaine Pain Relief Patch
Aspercreme Lidocaine Pain Relief Spray
aspirin
aspirin/caffeine
aspirin/chlorpheniramine/dextromethorphan/phenylephrine
aspirin/chlorpheniramine/phenylephrine
aspirin/dextromethorphan/phenylephrine
aspirin/dipyridamole
aspirin/omeprazole
Aspruzyo Sprinkle
Astagraf XL
Astelin
Astepro Allergy
Asthmanefrin
Atacand
Atacand HCT
Atacicept
atacicept
Atarax
atazanavir
atazanavir/cobicistat
Atelvia
atenolol
atenolol/chlorthalidone
atezolizumab
atezolizumab/hyaluronidase
Atgam
atidarsagene autotemcel
Ativan
Atmeksi
atogepant
atoltivimab/maftivimab/odesivimab
atomoxetine
Atoncy
Atorvaliq
atorvastatin
atovaquone
atovaquone/proguanil
atracurium
Atralin
atrasentan
Atripla
AtroPen
atropine
atropine ophthalmic
atropine/pralidoxime
Atrovent HFA
Atrovent Nasal
ATryn
Attruby
Atzumi
Aubagio
Aubra EQ
Aucatzyl
Audenz
Augmentin
Augmentin ES-600
Augmentin XR
Augtyro
Aukelso (denosumab-kyqq)
Auralgan (original formulation)
auranofin
Aurlumyn
Aurovela 1.5/30
Aurovela 1/20
Aurovela 24 Fe
Aurovela Fe 1.5/30
Aurovela Fe 1/20
Auryxia
Austedo
Austedo XR
autologous mesenchymal stem cell-neurotrophic factor (MSC-NTF) ce...
Auvelity
Auvi-Q
avacincaptad pegol intravitreal
avacopan
Avage
avalglucosidase alfa
Avalide
avanafil
Avandaryl
Avandia
avapritinib
Avapro
Avasopasem
avasopasem
Avastin
avatrombopag
Aveed
Aveeno Anti-Itch Concentrated Lotion
Aveeno Baby Calming Comfort Lotion
Aveeno Baby Daily Moisture Cream
Aveeno Baby Daily Moisture Lotion
Aveeno Baby Eczema Therapy Moisturizing Cream
Aveeno Baby Eczema Therapy Nighttime Balm
Aveeno Baby Eczema Therapy Soothing Bath Treatment
Aveeno Calm + Restore Skin Therapy Balm
Aveeno Daily Moisturizing Lotion
Aveeno Eczema Therapy Moisturizing Cream
Aveeno Eczema Therapy Nighttime Itch Relief Balm
Aveeno Eczema Therapy Rescue Relief Treatment Gel Cream
Aveeno Hydrocortisone Anti-Itch Cream
Aveeno Positively Radiant Clear Complexion
Aveeno Skin Relief Hand Cream
Aveeno Skin Relief Moisturizing Lotion
Aveeno Skin Relief Overnight Cream
Aveeno Soothing Bath Treatment
Avelox
avelumab
Averi
Avgemsi
Aviane
Avidoxy
Avinza
Avita
Avlayah (tividenofusp alfa-eknm)
Avmapki Fakzynja Co-Pack
Avodart
Avonex
Avopef
Avsola (infliximab-axxq)
Avtozma (tocilizumab-anoh)
avutometinib and defactinib
Avycaz
Avzivi (bevacizumab-tnjn)
Awiqli (insulin icodec-abae)
axatilimab
Axert
axicabtagene ciloleucel
Axid
Axiron
axitinib
Axtle
Aygestin
Ayvakit
azacitidine
Azactam
Azasan
AzaSite
azathioprine
Azedra
azelaic acid topical
azelastine nasal
azelastine ophthalmic
azelastine/fluticasone propionate nasal
Azelex
Azilect
azilsartan medoxomil
azilsartan medoxomil/chlorthalidone
azithromycin
azithromycin ophthalmic
Azmacort
Azmiro
Azo Urinary Pain Relief
Azo Urinary Pain Relief Maximum Strength
Azopt
Azor
Azstarys
aztreonam
aztreonam inhaled
aztreonam/avibactam
Azulfidine
Azulfidine EN-tabs
Azurette

close

 

Select a medication above to begin.

Ritalin

methylphenidate

Drug Monograph

  • Black Box Warnings
  • Adult Dosing
  • Peds Dosing
  • Contraindications/Cautions
  • Drug Interactions
  • Adverse Reactions
  • Safety/Monitoring
  • Pregnancy/Lactation
  • Pharmacology
  • Formulary
  • Manufacturer/Pricing
  • Patient Education
  • Pill Pictures
  • Add to Interaction Check
  • Dosing Calculator

Black Box Warnings .

Abuse, Misuse, and Addiction

CNS stimulants have high potential for abuse and misuse, can lead to substance use disorder, including addiction; misuse and abuse can result in overdose and death, risk incr. with higher doses or unapproved administration methods; assess risk for abuse, misuse, and addiction before prescribing and throughout tx; educate patients and families about risks and proper drug storage and disposal; monitor frequently for signs/symptoms of abuse, misuse, and addiction during tx

Adult Dosing .

Dosage forms:  TAB: 5 mg, 10 mg, 20 mg

Special Note

[strength clarification]
Info: all strengths expressed as methylphenidate hydrochloride

ADHD

[10-60 mg/day PO divided bid-tid]
Start: 5-10 mg PO bid, may incr. by 5-10 mg/day q7 days; Max: 60 mg/day; Info: duration 3-5h; give 30-45min before meals, last dose before 6pm

narcolepsy

[10-60 mg/day PO divided bid-tid]
Start: 5-10 mg PO bid, may incr. by 5-10 mg/day q7 days; Max: 60 mg/day; Info: give 30-45min before meals, last dose before 6pm

renal dosing

[not defined]
renal impairment: not defined
HD/PD: not defined

hepatic dosing

[not defined]

Peds Dosing .

Dosage forms:  TAB: 5 mg, 10 mg, 20 mg

Special Note

[strength clarification]
Info: all strengths expressed as methylphenidate hydrochloride

ADHD

[4-5 yo (off-label)]
Dose: 2.5-7.5 mg PO tid; Start: 2.5 mg PO bid, may incr. to 7.5 mg PO tid over 7 days; Max: 30 mg/day; Info: give 30-45min before meals, last dose before 6pm
[6 yo and older]
Dose: 0.3-2 mg/kg/day PO divided bid-tid; Start: 0.3 mg/kg/dose PO bid or 2.5-5 mg PO bid, may incr. by 0.1 mg/kg/dose or 5-10 mg/day q7 days; Max: 2 mg/kg/day up to 60 mg/day; Info: duration 3-5h; give 30-45min before meals, last dose before 6pm

renal dosing

[not defined]
renal impairment: not defined
HD/PD: not defined

hepatic dosing

[not defined]

Contraindications / Cautions .

    com.epocrates.rxweb.beans.StringCollection@1327d16e
  • hypersensitivity to drug or ingredient
  • MAO inhibitor use within 14 days
  • cardiac disease, severe
  • cardiac abnormality, structural
  • arrhythmia, severe
  • cardiomyopathy
  • CAD
  • fructose intolerance, hereditary (30% IR/70% ER cap form)
  • sucrase-isomaltase deficiency (30% IR/70% ER cap form)
  • glucose-galactose malabsorption (30% IR/70% ER cap form)
  • GI stricture, severe (qd ER tab form)
  • dysphagia (IR chewable tab form)
  • avoid: alcohol use (qd ER cap form)
  • caution: hypersensitivity to tartrazine (some generic forms)
  • caution: peds patients (ER form)
  • caution: HTN
  • caution: psychosis
  • caution: bipolar disorder
  • caution: bipolar disorder risk
  • caution: Tourette syndrome
  • caution: Tourette syndrome family history
  • caution: tic disorder
  • caution: tic disorder family history
  • caution: glaucoma risk, angle-closure
  • caution: glaucoma, open-angle
  • caution: IOP incr.
  • caution: substance abuse risk
  • caution: PKU (phenylalanine-containing form)

Drug Interactions .

Overview

methylphenidate

CNS stimulant

Interaction Characteristics:
  • gastric pH sensitive
  • hypertensive effects
  • potential for modified drug release
  • serotonergic effects
  • tachycardia
Other Info
  • add MAO inhibitor to Interaction Check if recent (14 days) use
  • avoid combo with beverages or products containing ethanol and some ER methylphenidate formulations (including capsule, chewable, oral suspension, ODT); combo may incr. methylphenidate release rate, levels, risk of adverse effects, decr. duration of efficacy

Contraindicated

  • benzphetamine
  • Ritalin (methylphenidate)
    +
    benzphetamine
    1 interaction

    Contraindicated

    methylphenidate + benzphetamine

    contraindicated: combo may incr. risk of tachycardia, HTN (additive effects, duplicate therapy)

  • isocarboxazid
  • Ritalin (methylphenidate)
    +
    isocarboxazid
    1 interaction

    Contraindicated

    methylphenidate + isocarboxazid

    contraindicated within 14 days of isocarboxazid use: combo may incr. risk of serotonin syndrome, HTN, including hypertensive crisis (additive effects)

  • linezolid
  • Ritalin (methylphenidate)
    +
    linezolid
    1 interaction

    Contraindicated

    methylphenidate + linezolid

    contraindicated within 14 days of linezolid use; hold methylphenidate if urgent use; monitor BP, serotonin syndrome symptoms x2wk after methylphenidate D/C or 24h after last linezolid dose: combo may incr. risk of serotonin syndrome, HTN, including hypertensive crisis (additive effects, linezolid reversibly inhibits monoamine oxidase)

  • methylene blue injection
  • Ritalin (methylphenidate)
    +
    methylene blue injection
    1 interaction

    Contraindicated

    methylphenidate + methylene blue injection

    contraindicated w/in 14 days of methylene blue use; hold methylphenidate if emergency use; monitor BP, serotonin syndrome sx up to 4h after last methylene blue dose; may resume methylphenidate 72h after last methylene blue dose: combo may incr. risk of serotonin syndrome, HTN, including hypertensive crisis (additive effects, methylene blue reversibly inhibits monoamine oxidase)

  • phendimetrazine
  • Ritalin (methylphenidate)
    +
    phendimetrazine
    1 interaction

    Contraindicated

    methylphenidate + phendimetrazine

    contraindicated: combo may incr. risk of tachycardia, HTN (additive effects)

  • phenelzine
  • Ritalin (methylphenidate)
    +
    phenelzine
    1 interaction

    Contraindicated

    methylphenidate + phenelzine

    contraindicated within 14 days of phenelzine use: combo may incr. risk of serotonin syndrome, HTN, including hypertensive crisis (additive effects)

  • rasagiline
  • Ritalin (methylphenidate)
    +
    rasagiline
    1 interaction

    Contraindicated

    methylphenidate + rasagiline

    contraindicated w/in 14 days of rasagiline use: combo may incr. risk of serotonin syndrome, HTN, including hypertensive crisis (additive effects)

  • safinamide
  • Ritalin (methylphenidate)
    +
    safinamide
    1 interaction

    Contraindicated

    methylphenidate + safinamide

    contraindicated w/in 14 days of safinamide use: combo may incr. risk of serotonin syndrome, HTN, including hypertensive crisis (additive effects)

  • selegiline
  • Ritalin (methylphenidate)
    +
    selegiline
    1 interaction

    Contraindicated

    methylphenidate + selegiline

    contraindicated w/in 14 days of selegiline use: combo may incr. risk of serotonin syndrome, HTN, including hypertensive crisis (additive effects)

  • selegiline transdermal
  • Ritalin (methylphenidate)
    +
    selegiline transdermal
    1 interaction

    Contraindicated

    methylphenidate + selegiline transdermal

    contraindicated within 14 days of selegiline use: combo may incr. risk of serotonin syndrome, HTN, including hypertensive crisis (additive effects)

  • tranylcypromine
  • Ritalin (methylphenidate)
    +
    tranylcypromine
    1 interaction

    Contraindicated

    methylphenidate + tranylcypromine

    contraindicated within 14 days of tranylcypromine use: combo may incr. risk of serotonin syndrome, HTN, including hypertensive crisis (additive effects)

  • yohimbe
  • Ritalin (methylphenidate)
    +
    yohimbe
    1 interaction

    Contraindicated

    methylphenidate + yohimbe

    contraindicated w/in 14 days of yohimbe use: combo may incr. risk of serotonin syndrome, HTN (including hypertensive crisis), tachycardia (additive effects, yohimbe inhibits monoamine oxidase)

Avoid/Use Alternative

  • albuterol
  • Ritalin (methylphenidate)
    +
    albuterol
    1 interaction

    Avoid/Use Alternative

    methylphenidate + albuterol

    use alternative or monitor BP, HR w/ oral albuterol; risk may be lower w/ inhaled albuterol: combo may incr. risk of HTN, tachycardia (additive effects)

  • alfentanil
  • Ritalin (methylphenidate)
    +
    alfentanil
    1 interaction

    Avoid/Use Alternative

    methylphenidate + alfentanil

    use alternative or monitor serotonin syndrome symptoms, especially during initiation/titration: combo may incr. risk of serotonin syndrome (additive effects)

  • aluminum hydroxide
  • Ritalin (methylphenidate)
    +
    aluminum hydroxide
    1 interaction

    Avoid/Use Alternative

    methylphenidate + aluminum hydroxide

    consider alternative w/ some oral methylphenidate ER formulations: combo may alter methylphenidate release, incr. risk of adverse effects or decr. efficacy (altered dissolution of ER methylphenidate at higher gastric pH)

  • amphetamine
  • Ritalin (methylphenidate)
    +
    amphetamine
    1 interaction

    Avoid/Use Alternative

    methylphenidate + amphetamine

    consider alternative or monitor BP, HR, serotonin syndrome symptoms, especially during initiation/titration; decr. amphetamine start dose: combo may incr. risk of HTN, tachycardia, serotonin syndrome, other adverse effects (additive effects, duplicate therapy)

  • buprenorphine
  • Ritalin (methylphenidate)
    +
    buprenorphine
    1 interaction

    Avoid/Use Alternative

    methylphenidate + buprenorphine

    use alternative or monitor serotonin syndrome symptoms, especially during initiation/titration: combo may incr. risk of serotonin syndrome (additive effects)

  • butorphanol
  • Ritalin (methylphenidate)
    +
    butorphanol
    1 interaction

    Avoid/Use Alternative

    methylphenidate + butorphanol

    use alternative or monitor serotonin syndrome symptoms, especially during initiation/titration: combo may incr. risk of serotonin syndrome (additive effects)

  • calcium carbonate
  • Ritalin (methylphenidate)
    +
    calcium carbonate
    1 interaction

    Avoid/Use Alternative

    methylphenidate + calcium carbonate

    consider alternative w/ some oral methylphenidate ER formulations: combo may alter methylphenidate release, incr. risk of adverse effects or decr. efficacy (altered dissolution of ER methylphenidate at higher gastric pH)

  • cimetidine
  • Ritalin (methylphenidate)
    +
    cimetidine
    1 interaction

    Avoid/Use Alternative

    methylphenidate + cimetidine

    consider alternative w/ some oral methylphenidate ER formulations: combo may alter methylphenidate release, incr. risk of adverse effects or decr. efficacy (altered dissolution of ER methylphenidate at higher gastric pH)

  • citalopram
  • Ritalin (methylphenidate)
    +
    citalopram
    1 interaction

    Avoid/Use Alternative

    methylphenidate + citalopram

    use alternative or monitor serotonin syndrome symptoms, especially during initiation/titration: combo may incr. risk of serotonin syndrome (additive effects)

  • clomipramine
  • Ritalin (methylphenidate)
    +
    clomipramine
    1 interaction

    Avoid/Use Alternative

    methylphenidate + clomipramine

    use alternative or monitor BP, HR, serotonin syndrome symptoms, especially during initiation/titration: combo may incr. clomipramine levels, risk of HTN, tachycardia, serotonin syndrome, other adverse effects (mechanism unknown, hepatic metabolism possibly inhibited, additive effects)

  • codeine
  • Ritalin (methylphenidate)
    +
    codeine
    1 interaction

    Avoid/Use Alternative

    methylphenidate + codeine

    use alternative or monitor serotonin syndrome symptoms, especially during initiation/titration: combo may incr. risk of serotonin syndrome (additive effects)

  • cyclobenzaprine
  • Ritalin (methylphenidate)
    +
    cyclobenzaprine
    1 interaction

    Avoid/Use Alternative

    methylphenidate + cyclobenzaprine

    use alternative or monitor serotonin syndrome symptoms, especially during initiation/titration: combo may incr. risk of serotonin syndrome (additive effects)

  • desipramine
  • Ritalin (methylphenidate)
    +
    desipramine
    1 interaction

    Avoid/Use Alternative

    methylphenidate + desipramine

    use alternative or monitor BP, HR, serotonin syndrome symptoms, especially during initiation/titration: combo may incr. risk of HTN, tachycardia, serotonin syndrome (additive effects)

  • desvenlafaxine
  • Ritalin (methylphenidate)
    +
    desvenlafaxine
    1 interaction

    Avoid/Use Alternative

    methylphenidate + desvenlafaxine

    use alternative or monitor BP, serotonin syndrome symptoms, especially during initiation/titration: combo may incr. risk of HTN, serotonin syndrome (additive effects)

  • dexlansoprazole
  • Ritalin (methylphenidate)
    +
    dexlansoprazole
    1 interaction

    Avoid/Use Alternative

    methylphenidate + dexlansoprazole

    consider alternative w/ some oral methylphenidate ER formulations: combo may alter methylphenidate release, incr. risk of adverse effects or decr. efficacy (altered dissolution of ER methylphenidate at higher gastric pH)

  • dexmethylphenidate
  • Ritalin (methylphenidate)
    +
    dexmethylphenidate
    1 interaction

    Avoid/Use Alternative

    methylphenidate + dexmethylphenidate

    consider alternative or monitor BP, HR, serotonin syndrome symptoms, especially during initiation/titration: combo may incr. risk of serotonin syndrome, HTN, tachycardia, other adverse effects (additive effects, duplicate therapy)

  • dextroamphetamine
  • Ritalin (methylphenidate)
    +
    dextroamphetamine
    1 interaction

    Avoid/Use Alternative

    methylphenidate + dextroamphetamine

    consider alternative or monitor BP, HR, serotonin syndrome symptoms, especially during initiation/titration; decr. dextroamphetamine start dose: combo may incr. risk of HTN, tachycardia, serotonin syndrome, other adverse effects (additive effects, duplicate therapy)

  • dihydrocodeine
  • Ritalin (methylphenidate)
    +
    dihydrocodeine
    1 interaction

    Avoid/Use Alternative

    methylphenidate + dihydrocodeine

    use alternative or monitor serotonin syndrome symptoms, especially during initiation/titration: combo may incr. risk of serotonin syndrome (additive effects)

  • dronabinol
  • Ritalin (methylphenidate)
    +
    dronabinol
    1 interaction

    Avoid/Use Alternative

    methylphenidate + dronabinol

    avoid combo: combo may incr. risk of HTN, tachycardia (additive effects)

  • duloxetine
  • Ritalin (methylphenidate)
    +
    duloxetine
    1 interaction

    Avoid/Use Alternative

    methylphenidate + duloxetine

    use alternative or monitor serotonin syndrome symptoms, especially during initiation/titration: combo may incr. risk of serotonin syndrome (additive effects)

  • ephedra
  • Ritalin (methylphenidate)
    +
    ephedra
    1 interaction

    Avoid/Use Alternative

    methylphenidate + ephedra

    avoid combo: combo may incr. risk of HTN, tachycardia, other cardiovascular adverse effects (additive effects)

  • epinephrine inhaled
  • Ritalin (methylphenidate)
    +
    epinephrine inhaled
    1 interaction

    Avoid/Use Alternative

    methylphenidate + epinephrine inhaled

    avoid combo: combo may incr. risk of tachycardia, HTN, including hypertensive crisis (additive effects)

  • escitalopram
  • Ritalin (methylphenidate)
    +
    escitalopram
    1 interaction

    Avoid/Use Alternative

    methylphenidate + escitalopram

    use alternative or monitor serotonin syndrome symptoms, especially during initiation/titration: combo may incr. risk of serotonin syndrome (additive effects)

  • esomeprazole
  • Ritalin (methylphenidate)
    +
    esomeprazole
    1 interaction

    Avoid/Use Alternative

    methylphenidate + esomeprazole

    consider alternative w/ some oral methylphenidate ER formulations: combo may alter methylphenidate release, incr. risk of adverse effects or decr. efficacy (altered dissolution of ER methylphenidate at higher gastric pH)

  • ethanol (alcoholic beverage)
  • Ritalin (methylphenidate)
    +
    ethanol (alcoholic beverage)
    1 interaction

    Avoid/Use Alternative

    methylphenidate + ethanol (alcoholic beverage)

    avoid combo with some ER methylphenidate formulations (including cap, chewable, oral suspension, ODT); otherwise, monitor BP: combo with all methylphenidate formulations may incr. risk of HTN (chronic alcohol use); coingestion of oral ethanol with some ER methylphenidate formulations may incr. methylphenidate levels, risk of adverse effects, decr. duration of methylphenidate efficacy; dose dumping not observed with methylphenidate ER tab and IR formulations (additive effects; rapid release from some methylphenidate ER formulations)

  • ethanol (in some formulations)
  • Ritalin (methylphenidate)
    +
    ethanol (in some formulations)
    1 interaction

    Avoid/Use Alternative

    methylphenidate + ethanol (in some formulations)

    avoid combo with some ER methylphenidate formulations (including cap, chewable, oral suspension, ODT): coingestion of oral ethanol may incr. methylphenidate levels, risk of adverse effects, decr. duration of methylphenidate efficacy; dose dumping not observed with methylphenidate ER tab and IR formulations (rapid release from some methylphenidate ER formulations)

  • famotidine
  • Ritalin (methylphenidate)
    +
    famotidine
    1 interaction

    Avoid/Use Alternative

    methylphenidate + famotidine

    consider alternative w/ some oral methylphenidate ER formulations: combo may alter methylphenidate release, incr. risk of adverse effects or decr. efficacy (altered dissolution of ER methylphenidate at higher gastric pH)

  • fentanyl
  • Ritalin (methylphenidate)
    +
    fentanyl
    1 interaction

    Avoid/Use Alternative

    methylphenidate + fentanyl

    use alternative or monitor serotonin syndrome symptoms, especially during initiation/titration: combo may incr. risk of serotonin syndrome (additive effects)

  • fluoxetine
  • Ritalin (methylphenidate)
    +
    fluoxetine
    1 interaction

    Avoid/Use Alternative

    methylphenidate + fluoxetine

    use alternative or monitor serotonin syndrome symptoms, especially during initiation/titration: combo may incr. risk of serotonin syndrome (additive effects)

  • fluvoxamine
  • Ritalin (methylphenidate)
    +
    fluvoxamine
    1 interaction

    Avoid/Use Alternative

    methylphenidate + fluvoxamine

    use alternative or monitor serotonin syndrome symptoms, especially during initiation/titration: combo may incr. risk of serotonin syndrome (additive effects)

  • furosemide
  • Ritalin (methylphenidate)
    +
    furosemide
    1 interaction

    Avoid/Use Alternative

    methylphenidate + furosemide

    use alternative or monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • gepirone
  • Ritalin (methylphenidate)
    +
    gepirone
    1 interaction

    Avoid/Use Alternative

    methylphenidate + gepirone

    use alternative or monitor serotonin syndrome sx, especially during initiation/titration: combo may incr. risk of serotonin syndrome (additive effects)

  • granisetron
  • Ritalin (methylphenidate)
    +
    granisetron
    1 interaction

    Avoid/Use Alternative

    methylphenidate + granisetron

    use alternative or monitor serotonin syndrome sx, especially during initiation/titration: combo may incr. risk of serotonin syndrome (additive effects)

  • hydrocodone
  • Ritalin (methylphenidate)
    +
    hydrocodone
    1 interaction

    Avoid/Use Alternative

    methylphenidate + hydrocodone

    use alternative or monitor serotonin syndrome symptoms, especially during initiation/titration: combo may incr. risk of serotonin syndrome (additive effects)

  • hydromorphone
  • Ritalin (methylphenidate)
    +
    hydromorphone
    1 interaction

    Avoid/Use Alternative

    methylphenidate + hydromorphone

    use alternative or monitor serotonin syndrome symptoms, especially during initiation/titration: combo may incr. risk of serotonin syndrome (additive effects)

  • isoniazid
  • Ritalin (methylphenidate)
    +
    isoniazid
    1 interaction

    Avoid/Use Alternative

    methylphenidate + isoniazid

    use alternative or monitor serotonin syndrome symptoms, especially during initiation/titration: combo may incr. risk of serotonin syndrome (additive effects, isoniazid inhibits monoamine oxidase)

  • landiolol
  • Ritalin (methylphenidate)
    +
    landiolol
    1 interaction

    Avoid/Use Alternative

    methylphenidate + landiolol

    use alternative or monitor HR, BP: combo may decr. landiolol efficacy (antagonistic effects)

  • lansoprazole
  • Ritalin (methylphenidate)
    +
    lansoprazole
    1 interaction

    Avoid/Use Alternative

    methylphenidate + lansoprazole

    consider alternative w/ some oral methylphenidate ER formulations: combo may alter methylphenidate release, incr. risk of adverse effects or decr. efficacy (altered dissolution of ER methylphenidate at higher gastric pH)

  • levomilnacipran
  • Ritalin (methylphenidate)
    +
    levomilnacipran
    1 interaction

    Avoid/Use Alternative

    methylphenidate + levomilnacipran

    use alternative or monitor BP, HR, serotonin syndrome symptoms, especially during initiation/titration: combo may incr. risk of serotonin syndrome, HTN, tachycardia (additive effects)

  • levorphanol
  • Ritalin (methylphenidate)
    +
    levorphanol
    1 interaction

    Avoid/Use Alternative

    methylphenidate + levorphanol

    use alternative or monitor serotonin syndrome symptoms, especially during initiation/titration: combo may incr. risk of serotonin syndrome (additive effects)

  • lisdexamfetamine
  • Ritalin (methylphenidate)
    +
    lisdexamfetamine
    1 interaction

    Avoid/Use Alternative

    methylphenidate + lisdexamfetamine

    consider alternative or decr. lisdexamfetamine start dose; monitor BP, HR, serotonin syndrome symptoms, especially during initiation/titration: combo may incr. risk of serotonin syndrome, HTN, tachycardia, other adverse effects (additive effects, duplicate therapy)

  • lithium
  • Ritalin (methylphenidate)
    +
    lithium
    1 interaction

    Avoid/Use Alternative

    methylphenidate + lithium

    use alternative or monitor serotonin syndrome symptoms, especially during initiation/titration: combo may incr. risk of serotonin syndrome (additive effects)

  • magnesium carbonate
  • Ritalin (methylphenidate)
    +
    magnesium carbonate
    1 interaction

    Avoid/Use Alternative

    methylphenidate + magnesium carbonate

    consider alternative w/ some oral methylphenidate ER formulations: combo may alter methylphenidate release, incr. risk of adverse effects or decr. efficacy (altered dissolution of ER methylphenidate at higher gastric pH)

  • magnesium hydroxide
  • Ritalin (methylphenidate)
    +
    magnesium hydroxide
    1 interaction

    Avoid/Use Alternative

    methylphenidate + magnesium hydroxide

    consider alternative w/ some oral methylphenidate ER formulations: combo may alter methylphenidate release, incr. risk of adverse effects or decr. efficacy (altered dissolution of ER methylphenidate at higher gastric pH)

  • magnesium oxide
  • Ritalin (methylphenidate)
    +
    magnesium oxide
    1 interaction

    Avoid/Use Alternative

    methylphenidate + magnesium oxide

    consider alternative w/ some oral methylphenidate ER formulations: combo may alter methylphenidate release, incr. risk of adverse effects or decr. efficacy (altered dissolution of ER methylphenidate at higher gastric pH)

  • meperidine
  • Ritalin (methylphenidate)
    +
    meperidine
    1 interaction

    Avoid/Use Alternative

    methylphenidate + meperidine

    use alternative or monitor serotonin syndrome symptoms, especially during initiation/titration: combo may incr. risk of serotonin syndrome (additive effects)

  • metaxalone
  • Ritalin (methylphenidate)
    +
    metaxalone
    1 interaction

    Avoid/Use Alternative

    methylphenidate + metaxalone

    use alternative or monitor serotonin syndrome sx, especially during initiation/titration: combo may incr. risk of serotonin syndrome (additive effects)

  • methadone
  • Ritalin (methylphenidate)
    +
    methadone
    1 interaction

    Avoid/Use Alternative

    methylphenidate + methadone

    use alternative or monitor serotonin syndrome symptoms, especially during initiation/titration: combo may incr. risk of serotonin syndrome (additive effects)

  • methamphetamine
  • Ritalin (methylphenidate)
    +
    methamphetamine
    1 interaction

    Avoid/Use Alternative

    methylphenidate + methamphetamine

    consider alternative or decr. methamphetamine start dose; monitor BP, HR, serotonin syndrome symptoms, especially during initiation/titration: combo may incr. risk of HTN, tachycardia, serotonin syndrome (additive effects, duplicate therapy)

  • methylene blue oral
  • Ritalin (methylphenidate)
    +
    methylene blue oral
    1 interaction

    Avoid/Use Alternative

    methylphenidate + methylene blue oral

    use alternative or monitor serotonin syndrome sx, especially during initiation/titration: combo may incr. risk of serotonin syndrome (additive effects, methylene blue reversibly inhibits monoamine oxidase)

  • midodrine
  • Ritalin (methylphenidate)
    +
    midodrine
    1 interaction

    Avoid/Use Alternative

    methylphenidate + midodrine

    use alternative or monitor BP: combo may incr. risk of HTN (additive effects)

  • milnacipran
  • Ritalin (methylphenidate)
    +
    milnacipran
    1 interaction

    Avoid/Use Alternative

    methylphenidate + milnacipran

    use alternative or monitor BP, HR, serotonin syndrome symptoms, especially during initiation/titration: combo may incr. risk of serotonin syndrome, HTN, tachycardia (additive effects)

  • mirtazapine
  • Ritalin (methylphenidate)
    +
    mirtazapine
    1 interaction

    Avoid/Use Alternative

    methylphenidate + mirtazapine

    use alternative or monitor serotonin syndrome symptoms, especially during initiation/titration: combo may incr. risk of serotonin syndrome (additive effects)

  • morphine
  • Ritalin (methylphenidate)
    +
    morphine
    1 interaction

    Avoid/Use Alternative

    methylphenidate + morphine

    use alternative or monitor serotonin syndrome symptoms, especially during initiation/titration: combo may incr. risk of serotonin syndrome (additive effects)

  • nalbuphine
  • Ritalin (methylphenidate)
    +
    nalbuphine
    1 interaction

    Avoid/Use Alternative

    methylphenidate + nalbuphine

    use alternative or monitor serotonin syndrome symptoms, especially during initiation/titration: combo may incr. risk of serotonin syndrome (additive effects)

  • nizatidine
  • Ritalin (methylphenidate)
    +
    nizatidine
    1 interaction

    Avoid/Use Alternative

    methylphenidate + nizatidine

    consider alternative w/ some oral methylphenidate ER formulations: combo may alter methylphenidate release, incr. risk of adverse effects or decr. efficacy (altered dissolution of ER methylphenidate at higher gastric pH)

  • nortriptyline
  • Ritalin (methylphenidate)
    +
    nortriptyline
    1 interaction

    Avoid/Use Alternative

    methylphenidate + nortriptyline

    use alternative or monitor BP, HR, serotonin syndrome symptoms, especially during initiation/titration: combo may incr. risk of HTN, tachycardia, serotonin syndrome (additive effects)

  • oliceridine
  • Ritalin (methylphenidate)
    +
    oliceridine
    1 interaction

    Avoid/Use Alternative

    methylphenidate + oliceridine

    use alternative or monitor serotonin syndrome symptoms, especially during initiation/titration: combo may incr. risk of serotonin syndrome (additive effects)

  • omeprazole
  • Ritalin (methylphenidate)
    +
    omeprazole
    1 interaction

    Avoid/Use Alternative

    methylphenidate + omeprazole

    consider alternative w/ some oral methylphenidate ER formulations: combo may alter methylphenidate release, incr. risk of adverse effects or decr. efficacy (altered dissolution of ER methylphenidate at higher gastric pH)

  • ondansetron
  • Ritalin (methylphenidate)
    +
    ondansetron
    1 interaction

    Avoid/Use Alternative

    methylphenidate + ondansetron

    use alternative or monitor serotonin syndrome sx, especially during initiation/titration: combo may incr. risk of serotonin syndrome (additive effects)

  • opium
  • Ritalin (methylphenidate)
    +
    opium
    1 interaction

    Avoid/Use Alternative

    methylphenidate + opium

    use alternative or monitor serotonin syndrome sx, especially during initiation/titration: combo may incr. risk of serotonin syndrome (additive effects)

  • oxycodone
  • Ritalin (methylphenidate)
    +
    oxycodone
    1 interaction

    Avoid/Use Alternative

    methylphenidate + oxycodone

    use alternative or monitor serotonin syndrome symptoms, especially during initiation/titration: combo may incr. risk of serotonin syndrome (additive effects)

  • oxymorphone
  • Ritalin (methylphenidate)
    +
    oxymorphone
    1 interaction

    Avoid/Use Alternative

    methylphenidate + oxymorphone

    use alternative or monitor serotonin syndrome symptoms, especially during initiation/titration: combo may incr. risk of serotonin syndrome (additive effects)

  • pantoprazole
  • Ritalin (methylphenidate)
    +
    pantoprazole
    1 interaction

    Avoid/Use Alternative

    methylphenidate + pantoprazole

    consider alternative w/ some oral methylphenidate ER formulations: combo may alter methylphenidate release, incr. risk of adverse effects or decr. efficacy (altered dissolution of ER methylphenidate at higher gastric pH)

  • paroxetine
  • Ritalin (methylphenidate)
    +
    paroxetine
    1 interaction

    Avoid/Use Alternative

    methylphenidate + paroxetine

    use alternative or monitor serotonin syndrome symptoms, especially during initiation/titration: combo may incr. risk of serotonin syndrome (additive effects)

  • pentazocine
  • Ritalin (methylphenidate)
    +
    pentazocine
    1 interaction

    Avoid/Use Alternative

    methylphenidate + pentazocine

    use alternative or monitor serotonin syndrome symptoms, especially during initiation/titration: combo may incr. risk of serotonin syndrome (additive effects)

  • procarbazine
  • Ritalin (methylphenidate)
    +
    procarbazine
    1 interaction

    Avoid/Use Alternative

    methylphenidate + procarbazine

    use alternative or monitor BP, serotonin syndrome symptoms, especially during initiation/titration: combo may incr. risk of serotonin syndrome, HTN, including hypertensive crisis (additive effects, procarbazine inhibits monoamine oxidase)

  • rabeprazole
  • Ritalin (methylphenidate)
    +
    rabeprazole
    1 interaction

    Avoid/Use Alternative

    methylphenidate + rabeprazole

    consider alternative w/ some oral methylphenidate ER formulations: combo may alter methylphenidate release, incr. risk of adverse effects or decr. efficacy (altered dissolution of ER methylphenidate at higher gastric pH)

  • remifentanil
  • Ritalin (methylphenidate)
    +
    remifentanil
    1 interaction

    Avoid/Use Alternative

    methylphenidate + remifentanil

    use alternative or monitor serotonin syndrome symptoms, especially during initiation/titration: combo may incr. risk of serotonin syndrome (additive effects)

  • sertraline
  • Ritalin (methylphenidate)
    +
    sertraline
    1 interaction

    Avoid/Use Alternative

    methylphenidate + sertraline

    use alternative or monitor serotonin syndrome symptoms, especially during initiation/titration: combo may incr. risk of serotonin syndrome (additive effects)

  • sodium bicarbonate
  • Ritalin (methylphenidate)
    +
    sodium bicarbonate
    1 interaction

    Avoid/Use Alternative

    methylphenidate + sodium bicarbonate

    consider alternative w/ some oral methylphenidate ER formulations and oral sodium bicarbonate: combo may alter methylphenidate release, incr. risk of adverse effects or decr. efficacy (altered dissolution of ER methylphenidate at higher gastric pH)

  • sodium citrate
  • Ritalin (methylphenidate)
    +
    sodium citrate
    1 interaction

    Avoid/Use Alternative

    methylphenidate + sodium citrate

    consider alternative w/ some oral methylphenidate ER formulations: combo may alter methylphenidate release, incr. risk of adverse effects or decr. efficacy (altered dissolution of ER methylphenidate at higher gastric pH)

  • sodium zirconium cyclosilicate
  • Ritalin (methylphenidate)
    +
    sodium zirconium cyclosilicate
    1 interaction

    Avoid/Use Alternative

    methylphenidate + sodium zirconium cyclosilicate

    consider alternative w/ some oral methylphenidate ER formulations: combo may alter methylphenidate release, incr. risk of adverse effects or decr. efficacy (altered dissolution of ER methylphenidate at higher gastric pH)

  • sufentanil
  • Ritalin (methylphenidate)
    +
    sufentanil
    1 interaction

    Avoid/Use Alternative

    methylphenidate + sufentanil

    use alternative or monitor serotonin syndrome symptoms, especially during initiation/titration: combo may incr. risk of serotonin syndrome (additive effects)

  • tapentadol
  • Ritalin (methylphenidate)
    +
    tapentadol
    1 interaction

    Avoid/Use Alternative

    methylphenidate + tapentadol

    use alternative or monitor serotonin syndrome symptoms, especially during initiation/titration: combo may incr. risk of serotonin syndrome (additive effects)

  • tedizolid
  • Ritalin (methylphenidate)
    +
    tedizolid
    1 interaction

    Avoid/Use Alternative

    methylphenidate + tedizolid

    use alternative or monitor serotonin syndrome symptoms, especially during initiation/titration: combo may incr. risk of serotonin syndrome (additive effects, tedizolid reversibly inhibits monoamine oxidase)

  • tipranavir
  • Ritalin (methylphenidate)
    +
    tipranavir
    1 interaction

    Avoid/Use Alternative

    methylphenidate + tipranavir

    avoid combo w/ ER methylphenidate formulations (incl. cap, chewable, oral suspension, ODT); methylphenidate ER tab and IR methylphenidate formulations OK: combo may incr. methylphenidate levels, risk of adverse effects (tipranavir capsules contain alcohol, alcohol causes more rapid release of methylphenidate dose)

  • tramadol
  • Ritalin (methylphenidate)
    +
    tramadol
    1 interaction

    Avoid/Use Alternative

    methylphenidate + tramadol

    use alternative or monitor serotonin syndrome symptoms, especially during initiation/titration: combo may incr. risk of serotonin syndrome (additive effects)

  • trimipramine
  • Ritalin (methylphenidate)
    +
    trimipramine
    1 interaction

    Avoid/Use Alternative

    methylphenidate + trimipramine

    use alternative or monitor BP, HR, serotonin syndrome symptoms, especially during initiation/titration: combo may incr. risk of HTN, tachycardia, serotonin syndrome (additive effects)

  • venlafaxine
  • Ritalin (methylphenidate)
    +
    venlafaxine
    1 interaction

    Avoid/Use Alternative

    methylphenidate + venlafaxine

    use alternative or monitor BP, serotonin syndrome symptoms, especially during initiation/titration: combo may incr. risk of serotonin syndrome, HTN (additive effects)

  • vilazodone
  • Ritalin (methylphenidate)
    +
    vilazodone
    1 interaction

    Avoid/Use Alternative

    methylphenidate + vilazodone

    use alternative or monitor serotonin syndrome symptoms, especially during initiation/titration: combo may incr. risk of serotonin syndrome (additive effects)

  • vonoprazan
  • Ritalin (methylphenidate)
    +
    vonoprazan
    1 interaction

    Avoid/Use Alternative

    methylphenidate + vonoprazan

    consider alternative w/ some oral methylphenidate ER formulations: combo may alter methylphenidate release, incr. risk of adverse effects or decr. efficacy (altered dissolution of ER methylphenidate at higher gastric pH)

  • vortioxetine
  • Ritalin (methylphenidate)
    +
    vortioxetine
    1 interaction

    Avoid/Use Alternative

    methylphenidate + vortioxetine

    use alternative or monitor serotonin syndrome sx, especially during initiation/titration: combo may incr. risk of serotonin syndrome (additive effects)

  • ziprasidone
  • Ritalin (methylphenidate)
    +
    ziprasidone
    1 interaction

    Avoid/Use Alternative

    methylphenidate + ziprasidone

    use alternative or monitor serotonin syndrome symptoms, especially during initiation/titration: combo may incr. risk of serotonin syndrome (additive effects)

Monitor/Modify Tx

  • 5-HTP
  • Ritalin (methylphenidate)
    +
    5-HTP
    1 interaction

    Monitor/Modify Tx

    methylphenidate + 5-HTP

    monitor serotonin syndrome sx, especially during initiation/titration: combo may incr. risk of serotonin syndrome (additive effects)

  • abiraterone acetate
  • Ritalin (methylphenidate)
    +
    abiraterone acetate
    1 interaction

    Monitor/Modify Tx

    methylphenidate + abiraterone acetate

    monitor BP: combo may incr. risk of HTN (additive effects)

  • acebutolol
  • Ritalin (methylphenidate)
    +
    acebutolol
    1 interaction

    Monitor/Modify Tx

    methylphenidate + acebutolol

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • albuterol inhaled
  • Ritalin (methylphenidate)
    +
    albuterol inhaled
    1 interaction

    Monitor/Modify Tx

    methylphenidate + albuterol inhaled

    monitor BP, HR: combo may incr. risk of HTN, tachycardia, other cardiovascular adverse effects (additive effects)

  • aliskiren
  • Ritalin (methylphenidate)
    +
    aliskiren
    1 interaction

    Monitor/Modify Tx

    methylphenidate + aliskiren

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • almotriptan
  • Ritalin (methylphenidate)
    +
    almotriptan
    1 interaction

    Monitor/Modify Tx

    methylphenidate + almotriptan

    monitor BP, serotonin syndrome sx, especially during initiation/titration: combo may incr. risk of HTN, serotonin syndrome (additive effects)

  • amiloride
  • Ritalin (methylphenidate)
    +
    amiloride
    1 interaction

    Monitor/Modify Tx

    methylphenidate + amiloride

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • amitriptyline
  • Ritalin (methylphenidate)
    +
    amitriptyline
    1 interaction

    Monitor/Modify Tx

    methylphenidate + amitriptyline

    monitor BP, HR, serotonin syndrome symptoms, especially during initiation/titration: combo may incr. risk of HTN, tachycardia, serotonin syndrome (additive effects)

  • amlodipine
  • Ritalin (methylphenidate)
    +
    amlodipine
    1 interaction

    Monitor/Modify Tx

    methylphenidate + amlodipine

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • amoxapine
  • Ritalin (methylphenidate)
    +
    amoxapine
    1 interaction

    Monitor/Modify Tx

    methylphenidate + amoxapine

    monitor BP, HR, serotonin syndrome symptoms, especially during initiation/titration: combo may incr. risk of HTN, tachycardia, serotonin syndrome (additive effects)

  • angiotensin II
  • Ritalin (methylphenidate)
    +
    angiotensin II
    1 interaction

    Monitor/Modify Tx

    methylphenidate + angiotensin II

    monitor BP: combo may incr. risk of HTN (additive effects)

  • aprocitentan
  • Ritalin (methylphenidate)
    +
    aprocitentan
    1 interaction

    Monitor/Modify Tx

    methylphenidate + aprocitentan

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • arformoterol inhaled
  • Ritalin (methylphenidate)
    +
    arformoterol inhaled
    1 interaction

    Monitor/Modify Tx

    methylphenidate + arformoterol inhaled

    monitor BP, HR: combo may incr. risk of HTN, tachycardia, other cardiovascular adverse effects (additive effects)

  • armodafinil
  • Ritalin (methylphenidate)
    +
    armodafinil
    1 interaction

    Monitor/Modify Tx

    methylphenidate + armodafinil

    monitor BP, HR: combo may incr. risk of HTN, tachycardia (additive effects)

  • asciminib
  • Ritalin (methylphenidate)
    +
    asciminib
    1 interaction

    Monitor/Modify Tx

    methylphenidate + asciminib

    monitor BP: combo may incr. risk of HTN (additive effects)

  • atenolol
  • Ritalin (methylphenidate)
    +
    atenolol
    1 interaction

    Monitor/Modify Tx

    methylphenidate + atenolol

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • atogepant
  • Ritalin (methylphenidate)
    +
    atogepant
    1 interaction

    Monitor/Modify Tx

    methylphenidate + atogepant

    monitor BP: combo may incr. risk of HTN (additive effects)

  • atropine
  • Ritalin (methylphenidate)
    +
    atropine
    1 interaction

    Monitor/Modify Tx

    methylphenidate + atropine

    monitor HR: combo may incr. risk of tachycardia (additive effects)

  • atropine ophthalmic
  • Ritalin (methylphenidate)
    +
    atropine ophthalmic
    1 interaction

    Monitor/Modify Tx

    methylphenidate + atropine ophthalmic

    monitor BP: combo may incr. risk of HTN (additive effects)

  • axitinib
  • Ritalin (methylphenidate)
    +
    axitinib
    1 interaction

    Monitor/Modify Tx

    methylphenidate + axitinib

    monitor BP: combo may incr. risk of HTN (additive effects)

  • azilsartan medoxomil
  • Ritalin (methylphenidate)
    +
    azilsartan medoxomil
    1 interaction

    Monitor/Modify Tx

    methylphenidate + azilsartan medoxomil

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • benazepril
  • Ritalin (methylphenidate)
    +
    benazepril
    1 interaction

    Monitor/Modify Tx

    methylphenidate + benazepril

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • benztropine
  • Ritalin (methylphenidate)
    +
    benztropine
    1 interaction

    Monitor/Modify Tx

    methylphenidate + benztropine

    monitor HR: combo may incr. risk of tachycardia (additive effects)

  • betamethasone
  • Ritalin (methylphenidate)
    +
    betamethasone
    1 interaction

    Monitor/Modify Tx

    methylphenidate + betamethasone

    monitor BP: combo may incr. risk of HTN (additive effects)

  • betaxolol
  • Ritalin (methylphenidate)
    +
    betaxolol
    1 interaction

    Monitor/Modify Tx

    methylphenidate + betaxolol

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • bevacizumab
  • Ritalin (methylphenidate)
    +
    bevacizumab
    1 interaction

    Monitor/Modify Tx

    methylphenidate + bevacizumab

    monitor BP: combo may incr. risk of HTN (additive effects)

  • bismuth subsalicylate
  • Ritalin (methylphenidate)
    +
    bismuth subsalicylate
    1 interaction

    Monitor/Modify Tx

    methylphenidate + bismuth subsalicylate

    monitor BP w/ high-dose bismuth subsalicylate: combo may incr. risk of HTN (additive effects)

  • bisoprolol
  • Ritalin (methylphenidate)
    +
    bisoprolol
    1 interaction

    Monitor/Modify Tx

    methylphenidate + bisoprolol

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • black cohosh
  • Ritalin (methylphenidate)
    +
    black cohosh
    1 interaction

    Monitor/Modify Tx

    methylphenidate + black cohosh

    monitor serotonin syndrome sx, especially during initiation/titration: combo may incr. risk of serotonin syndrome (additive effects)

  • brigatinib
  • Ritalin (methylphenidate)
    +
    brigatinib
    1 interaction

    Monitor/Modify Tx

    methylphenidate + brigatinib

    monitor BP: combo may incr. risk of HTN (additive effects)

  • bromocriptine
  • Ritalin (methylphenidate)
    +
    bromocriptine
    1 interaction

    Monitor/Modify Tx

    methylphenidate + bromocriptine

    monitor serotonin syndrome sx, especially during initiation/titration: combo may incr. risk of serotonin syndrome (additive effects)

  • budesonide
  • Ritalin (methylphenidate)
    +
    budesonide
    1 interaction

    Monitor/Modify Tx

    methylphenidate + budesonide

    monitor BP: combo may incr. risk of HTN (additive effects)

  • bumetanide
  • Ritalin (methylphenidate)
    +
    bumetanide
    1 interaction

    Monitor/Modify Tx

    methylphenidate + bumetanide

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • bupropion
  • Ritalin (methylphenidate)
    +
    bupropion
    1 interaction

    Monitor/Modify Tx

    methylphenidate + bupropion

    monitor BP: combo may incr. risk of HTN (additive effects)

  • buspirone
  • Ritalin (methylphenidate)
    +
    buspirone
    1 interaction

    Monitor/Modify Tx

    methylphenidate + buspirone

    monitor serotonin syndrome sx, especially during initiation/titration: combo may incr. risk of serotonin syndrome (additive effects)

  • cabozantinib
  • Ritalin (methylphenidate)
    +
    cabozantinib
    1 interaction

    Monitor/Modify Tx

    methylphenidate + cabozantinib

    monitor BP: combo may incr. risk of HTN (additive effects)

  • caffeine
  • Ritalin (methylphenidate)
    +
    caffeine
    1 interaction

    Monitor/Modify Tx

    methylphenidate + caffeine

    monitor BP, HR; avoid excessive caffeine intake: combo may incr. risk of HTN, tachycardia (additive effects)

  • caffeine citrate
  • Ritalin (methylphenidate)
    +
    caffeine citrate
    1 interaction

    Monitor/Modify Tx

    methylphenidate + caffeine citrate

    monitor BP, HR: combo may incr. risk of HTN, tachycardia (additive effects)

  • candesartan cilexetil
  • Ritalin (methylphenidate)
    +
    candesartan cilexetil
    1 interaction

    Monitor/Modify Tx

    methylphenidate + candesartan cilexetil

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • cannabis
  • Ritalin (methylphenidate)
    +
    cannabis
    1 interaction

    Monitor/Modify Tx

    methylphenidate + cannabis

    monitor BP, HR: combo may incr. risk of HTN, tachycardia (additive effects)

  • captopril
  • Ritalin (methylphenidate)
    +
    captopril
    1 interaction

    Monitor/Modify Tx

    methylphenidate + captopril

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • carbamazepine
  • Ritalin (methylphenidate)
    +
    carbamazepine
    1 interaction

    Monitor/Modify Tx

    methylphenidate + carbamazepine

    monitor serotonin syndrome symptoms, especially during initiation/titration: combo may incr. risk of serotonin syndrome (additive effects)

  • carfilzomib
  • Ritalin (methylphenidate)
    +
    carfilzomib
    1 interaction

    Monitor/Modify Tx

    methylphenidate + carfilzomib

    monitor BP: combo may incr. risk of HTN (additive effects)

  • carvedilol
  • Ritalin (methylphenidate)
    +
    carvedilol
    1 interaction

    Monitor/Modify Tx

    methylphenidate + carvedilol

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • celecoxib
  • Ritalin (methylphenidate)
    +
    celecoxib
    1 interaction

    Monitor/Modify Tx

    methylphenidate + celecoxib

    monitor BP: combo may incr. risk of HTN (additive effects)

  • chlorothiazide
  • Ritalin (methylphenidate)
    +
    chlorothiazide
    1 interaction

    Monitor/Modify Tx

    methylphenidate + chlorothiazide

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • chlorthalidone
  • Ritalin (methylphenidate)
    +
    chlorthalidone
    1 interaction

    Monitor/Modify Tx

    methylphenidate + chlorthalidone

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • clevidipine
  • Ritalin (methylphenidate)
    +
    clevidipine
    1 interaction

    Monitor/Modify Tx

    methylphenidate + clevidipine

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • clonidine
  • Ritalin (methylphenidate)
    +
    clonidine
    1 interaction

    Monitor/Modify Tx

    methylphenidate + clonidine

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • cocaine
  • Ritalin (methylphenidate)
    +
    cocaine
    1 interaction

    Monitor/Modify Tx

    methylphenidate + cocaine

    monitor BP, HR, serotonin syndrome symptoms, especially during initiation/titration: combo may incr. risk of HTN, tachycardia, serotonin syndrome (additive effects)

  • copanlisib
  • Ritalin (methylphenidate)
    +
    copanlisib
    1 interaction

    Monitor/Modify Tx

    methylphenidate + copanlisib

    monitor BP: combo may incr. risk of HTN (additive effects, copanlisib may cause infusion-related HTN)

  • corticotropin
  • Ritalin (methylphenidate)
    +
    corticotropin
    1 interaction

    Monitor/Modify Tx

    methylphenidate + corticotropin

    monitor BP: combo may incr. risk of HTN (additive effects)

  • cortisone
  • Ritalin (methylphenidate)
    +
    cortisone
    1 interaction

    Monitor/Modify Tx

    methylphenidate + cortisone

    monitor BP: combo may incr. risk of HTN (additive effects)

  • cyclosporine
  • Ritalin (methylphenidate)
    +
    cyclosporine
    1 interaction

    Monitor/Modify Tx

    methylphenidate + cyclosporine

    monitor BP: combo may incr. risk of HTN (additive effects)

  • danazol
  • Ritalin (methylphenidate)
    +
    danazol
    1 interaction

    Monitor/Modify Tx

    methylphenidate + danazol

    monitor BP: combo may incr. risk of HTN (additive effects)

  • darbepoetin alfa
  • Ritalin (methylphenidate)
    +
    darbepoetin alfa
    1 interaction

    Monitor/Modify Tx

    methylphenidate + darbepoetin alfa

    monitor BP: combo may incr. risk of HTN (additive effects)

  • deflazacort
  • Ritalin (methylphenidate)
    +
    deflazacort
    1 interaction

    Monitor/Modify Tx

    methylphenidate + deflazacort

    monitor BP: combo may incr. risk of HTN (additive effects)

  • desflurane
  • Ritalin (methylphenidate)
    +
    desflurane
    1 interaction

    Monitor/Modify Tx

    methylphenidate + desflurane

    D/C methylphenidate day of surgery: combo may incr. risk of intraoperative HTN, tachycardia (mechanism unknown)

  • desmopressin
  • Ritalin (methylphenidate)
    +
    desmopressin
    1 interaction

    Monitor/Modify Tx

    methylphenidate + desmopressin

    monitor BP: combo may incr. risk of HTN (additive effects)

  • dexamethasone
  • Ritalin (methylphenidate)
    +
    dexamethasone
    1 interaction

    Monitor/Modify Tx

    methylphenidate + dexamethasone

    monitor BP: combo may incr. risk of HTN (additive effects)

  • dextromethorphan
  • Ritalin (methylphenidate)
    +
    dextromethorphan
    1 interaction

    Monitor/Modify Tx

    methylphenidate + dextromethorphan

    monitor serotonin syndrome sx, especially during initiation/titration: combo may incr. risk of serotonin syndrome (additive effects)

  • diclofenac
  • Ritalin (methylphenidate)
    +
    diclofenac
    1 interaction

    Monitor/Modify Tx

    methylphenidate + diclofenac

    monitor BP: combo may incr. risk of HTN (additive effects)

  • diclofenac topical
  • Ritalin (methylphenidate)
    +
    diclofenac topical
    1 interaction

    Monitor/Modify Tx

    methylphenidate + diclofenac topical

    monitor BP: combo may incr. risk of HTN (additive effects)

  • dicyclomine
  • Ritalin (methylphenidate)
    +
    dicyclomine
    1 interaction

    Monitor/Modify Tx

    methylphenidate + dicyclomine

    monitor HR: combo may incr. risk of tachycardia (additive effects)

  • diethylpropion
  • Ritalin (methylphenidate)
    +
    diethylpropion
    1 interaction

    Monitor/Modify Tx

    methylphenidate + diethylpropion

    monitor BP, HR: combo may incr. risk of HTN, tachycardia (additive effects)

  • diflunisal
  • Ritalin (methylphenidate)
    +
    diflunisal
    1 interaction

    Monitor/Modify Tx

    methylphenidate + diflunisal

    monitor BP: combo may incr. risk of HTN (additive effects)

  • dihydroergotamine
  • Ritalin (methylphenidate)
    +
    dihydroergotamine
    1 interaction

    Monitor/Modify Tx

    methylphenidate + dihydroergotamine

    monitor BP, serotonin syndrome sx, especially during initiation/titration: combo may incr. risk of severe HTN, vasospasm, ischemia, serotonin syndrome (additive effects)

  • diltiazem
  • Ritalin (methylphenidate)
    +
    diltiazem
    1 interaction

    Monitor/Modify Tx

    methylphenidate + diltiazem

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • dobutamine
  • Ritalin (methylphenidate)
    +
    dobutamine
    1 interaction

    Monitor/Modify Tx

    methylphenidate + dobutamine

    monitor BP, HR: combo may incr. risk of HTN, tachycardia (additive effects)

  • dopamine
  • Ritalin (methylphenidate)
    +
    dopamine
    1 interaction

    Monitor/Modify Tx

    methylphenidate + dopamine

    monitor BP, HR: combo may incr. risk of HTN, tachycardia (additive effects)

  • doxapram
  • Ritalin (methylphenidate)
    +
    doxapram
    1 interaction

    Monitor/Modify Tx

    methylphenidate + doxapram

    monitor BP: combo may incr. risk of HTN (additive effects)

  • doxazosin
  • Ritalin (methylphenidate)
    +
    doxazosin
    1 interaction

    Monitor/Modify Tx

    methylphenidate + doxazosin

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • doxepin
  • Ritalin (methylphenidate)
    +
    doxepin
    1 interaction

    Monitor/Modify Tx

    methylphenidate + doxepin

    monitor BP, HR, serotonin syndrome symptoms, especially during initiation/titration: combo may incr. risk of HTN, tachycardia, serotonin syndrome (additive effects)

  • doxepin topical
  • Ritalin (methylphenidate)
    +
    doxepin topical
    1 interaction

    Monitor/Modify Tx

    methylphenidate + doxepin topical

    monitor serotonin syndrome sx, especially during initiation/titration: combo may incr. risk of serotonin syndrome (additive effects)

  • droxidopa
  • Ritalin (methylphenidate)
    +
    droxidopa
    1 interaction

    Monitor/Modify Tx

    methylphenidate + droxidopa

    monitor BP: combo may incr. risk of supine HTN (additive effects)

  • eletriptan
  • Ritalin (methylphenidate)
    +
    eletriptan
    1 interaction

    Monitor/Modify Tx

    methylphenidate + eletriptan

    monitor BP, serotonin syndrome sx, especially during initiation/titration: combo may incr. risk of HTN, serotonin syndrome (additive effects)

  • enalapril
  • Ritalin (methylphenidate)
    +
    enalapril
    1 interaction

    Monitor/Modify Tx

    methylphenidate + enalapril

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • enalaprilat
  • Ritalin (methylphenidate)
    +
    enalaprilat
    1 interaction

    Monitor/Modify Tx

    methylphenidate + enalaprilat

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • ephedrine injection
  • Ritalin (methylphenidate)
    +
    ephedrine injection
    1 interaction

    Monitor/Modify Tx

    methylphenidate + ephedrine injection

    monitor BP, HR: combo may incr. risk of HTN, tachycardia (additive effects)

  • ephedrine oral
  • Ritalin (methylphenidate)
    +
    ephedrine oral
    1 interaction

    Monitor/Modify Tx

    methylphenidate + ephedrine oral

    monitor BP, HR: combo may incr. risk of HTN, tachycardia (additive effects)

  • epinephrine
  • Ritalin (methylphenidate)
    +
    epinephrine
    1 interaction

    Monitor/Modify Tx

    methylphenidate + epinephrine

    monitor BP, HR: combo may incr. risk of HTN, tachycardia (additive effects)

  • eplerenone
  • Ritalin (methylphenidate)
    +
    eplerenone
    1 interaction

    Monitor/Modify Tx

    methylphenidate + eplerenone

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • epoetin alfa
  • Ritalin (methylphenidate)
    +
    epoetin alfa
    1 interaction

    Monitor/Modify Tx

    methylphenidate + epoetin alfa

    monitor BP: combo may incr. risk of HTN (additive effects)

  • eptinezumab
  • Ritalin (methylphenidate)
    +
    eptinezumab
    1 interaction

    Monitor/Modify Tx

    methylphenidate + eptinezumab

    monitor BP: combo may incr. risk of HTN (additive effects)

  • erenumab
  • Ritalin (methylphenidate)
    +
    erenumab
    1 interaction

    Monitor/Modify Tx

    methylphenidate + erenumab

    monitor BP: combo may incr. risk of HTN (additive effects)

  • ergotamine
  • Ritalin (methylphenidate)
    +
    ergotamine
    1 interaction

    Monitor/Modify Tx

    methylphenidate + ergotamine

    monitor BP, serotonin syndrome sx, especially during initiation/titration: combo may incr. risk of severe HTN, vasospasm, ischemia, serotonin syndrome (additive effects)

  • esketamine
  • Ritalin (methylphenidate)
    +
    esketamine
    1 interaction

    Monitor/Modify Tx

    methylphenidate + esketamine

    monitor BP: combo may incr. risk of HTN (additive effects)

  • esmolol
  • Ritalin (methylphenidate)
    +
    esmolol
    1 interaction

    Monitor/Modify Tx

    methylphenidate + esmolol

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • estetrol (contraceptive)
  • Ritalin (methylphenidate)
    +
    estetrol (contraceptive)
    1 interaction

    Monitor/Modify Tx

    methylphenidate + estetrol (contraceptive)

    monitor BP: combo may incr. risk of HTN (additive effects)

  • estradiol (contraceptive)
  • Ritalin (methylphenidate)
    +
    estradiol (contraceptive)
    1 interaction

    Monitor/Modify Tx

    methylphenidate + estradiol (contraceptive)

    monitor BP: combo may incr. risk of HTN (additive effects)

  • ethacrynic acid
  • Ritalin (methylphenidate)
    +
    ethacrynic acid
    1 interaction

    Monitor/Modify Tx

    methylphenidate + ethacrynic acid

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • ethinyl estradiol (contraceptive)
  • Ritalin (methylphenidate)
    +
    ethinyl estradiol (contraceptive)
    1 interaction

    Monitor/Modify Tx

    methylphenidate + ethinyl estradiol (contraceptive)

    monitor BP: combo may incr. risk of HTN (additive effects)

  • etodolac
  • Ritalin (methylphenidate)
    +
    etodolac
    1 interaction

    Monitor/Modify Tx

    methylphenidate + etodolac

    monitor BP: combo may incr. risk of HTN (additive effects)

  • etrasimod
  • Ritalin (methylphenidate)
    +
    etrasimod
    1 interaction

    Monitor/Modify Tx

    methylphenidate + etrasimod

    monitor BP: combo may incr. risk of HTN (additive effects)

  • felodipine
  • Ritalin (methylphenidate)
    +
    felodipine
    1 interaction

    Monitor/Modify Tx

    methylphenidate + felodipine

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • fenfluramine
  • Ritalin (methylphenidate)
    +
    fenfluramine
    1 interaction

    Monitor/Modify Tx

    methylphenidate + fenfluramine

    monitor BP, serotonin syndrome symptoms, especially during initiation/titration: combo may incr. risk of HTN (including hypertensive crisis), serotonin syndrome (additive effects)

  • fenoldopam
  • Ritalin (methylphenidate)
    +
    fenoldopam
    1 interaction

    Monitor/Modify Tx

    methylphenidate + fenoldopam

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • fenoprofen
  • Ritalin (methylphenidate)
    +
    fenoprofen
    1 interaction

    Monitor/Modify Tx

    methylphenidate + fenoprofen

    monitor BP: combo may incr. risk of HTN (additive effects)

  • fingolimod
  • Ritalin (methylphenidate)
    +
    fingolimod
    1 interaction

    Monitor/Modify Tx

    methylphenidate + fingolimod

    monitor BP: combo may incr. risk of HTN (additive effects)

  • fludrocortisone
  • Ritalin (methylphenidate)
    +
    fludrocortisone
    1 interaction

    Monitor/Modify Tx

    methylphenidate + fludrocortisone

    monitor BP: combo may incr. risk of HTN (additive effects)

  • flurbiprofen
  • Ritalin (methylphenidate)
    +
    flurbiprofen
    1 interaction

    Monitor/Modify Tx

    methylphenidate + flurbiprofen

    monitor BP: combo may incr. risk of HTN (additive effects)

  • formoterol inhaled
  • Ritalin (methylphenidate)
    +
    formoterol inhaled
    1 interaction

    Monitor/Modify Tx

    methylphenidate + formoterol inhaled

    monitor BP, HR: combo may incr. risk of HTN, tachycardia, other cardiovascular adverse effects (additive effects)

  • fosinopril
  • Ritalin (methylphenidate)
    +
    fosinopril
    1 interaction

    Monitor/Modify Tx

    methylphenidate + fosinopril

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • fosphenytoin
  • Ritalin (methylphenidate)
    +
    fosphenytoin
    1 interaction

    Monitor/Modify Tx

    methylphenidate + fosphenytoin

    monitor phenytoin levels: combo may incr. phenytoin levels, risk of toxicity (mechanism unknown, hepatic metabolism possibly inhibited)

  • fostamatinib
  • Ritalin (methylphenidate)
    +
    fostamatinib
    1 interaction

    Monitor/Modify Tx

    methylphenidate + fostamatinib

    monitor BP: combo may incr. risk of HTN (additive effects)

  • fremanezumab
  • Ritalin (methylphenidate)
    +
    fremanezumab
    1 interaction

    Monitor/Modify Tx

    methylphenidate + fremanezumab

    monitor BP: combo may incr. risk of HTN (additive effects)

  • frovatriptan
  • Ritalin (methylphenidate)
    +
    frovatriptan
    1 interaction

    Monitor/Modify Tx

    methylphenidate + frovatriptan

    monitor BP, serotonin syndrome sx, especially during initiation/titration: combo may incr. risk of HTN, serotonin syndrome (additive effects)

  • fruquintinib
  • Ritalin (methylphenidate)
    +
    fruquintinib
    1 interaction

    Monitor/Modify Tx

    methylphenidate + fruquintinib

    monitor BP: combo may incr. risk of HTN, including hypertensive crisis (additive effects)

  • galcanezumab
  • Ritalin (methylphenidate)
    +
    galcanezumab
    1 interaction

    Monitor/Modify Tx

    methylphenidate + galcanezumab

    monitor BP: combo may incr. risk of HTN (additive effects)

  • glycopyrrolate
  • Ritalin (methylphenidate)
    +
    glycopyrrolate
    1 interaction

    Monitor/Modify Tx

    methylphenidate + glycopyrrolate

    monitor HR: combo may incr. risk of tachycardia (additive effects)

  • guanfacine
  • Ritalin (methylphenidate)
    +
    guanfacine
    1 interaction

    Monitor/Modify Tx

    methylphenidate + guanfacine

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • hoodia
  • Ritalin (methylphenidate)
    +
    hoodia
    1 interaction

    Monitor/Modify Tx

    methylphenidate + hoodia

    monitor BP, HR: combo may incr. risk of HTN, tachycardia (additive effects)

  • hydralazine
  • Ritalin (methylphenidate)
    +
    hydralazine
    1 interaction

    Monitor/Modify Tx

    methylphenidate + hydralazine

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • hydrochlorothiazide
  • Ritalin (methylphenidate)
    +
    hydrochlorothiazide
    1 interaction

    Monitor/Modify Tx

    methylphenidate + hydrochlorothiazide

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • hydrocortisone
  • Ritalin (methylphenidate)
    +
    hydrocortisone
    1 interaction

    Monitor/Modify Tx

    methylphenidate + hydrocortisone

    monitor BP: combo may incr. risk of HTN (additive effects)

  • hydroxocobalamin IV
  • Ritalin (methylphenidate)
    +
    hydroxocobalamin IV
    1 interaction

    Monitor/Modify Tx

    methylphenidate + hydroxocobalamin IV

    monitor BP: combo may incr. risk of HTN (additive effects)

  • hyoscyamine
  • Ritalin (methylphenidate)
    +
    hyoscyamine
    1 interaction

    Monitor/Modify Tx

    methylphenidate + hyoscyamine

    monitor HR: combo may incr. risk of tachycardia (additive effects)

  • ibrutinib
  • Ritalin (methylphenidate)
    +
    ibrutinib
    1 interaction

    Monitor/Modify Tx

    methylphenidate + ibrutinib

    monitor BP: combo may incr. risk of HTN (additive effects)

  • ibuprofen
  • Ritalin (methylphenidate)
    +
    ibuprofen
    1 interaction

    Monitor/Modify Tx

    methylphenidate + ibuprofen

    monitor BP: combo may incr. risk of HTN (additive effects)

  • imipramine
  • Ritalin (methylphenidate)
    +
    imipramine
    1 interaction

    Monitor/Modify Tx

    methylphenidate + imipramine

    monitor BP, HR, serotonin syndrome symptoms, especially during initiation/titration; consider monitoring imipramine levels: combo may incr. imipramine levels, risk of HTN, tachycardia, serotonin syndrome, other adverse effects (mechanism unknown, hepatic metabolism possibly inhibited, additive effects)

  • indapamide
  • Ritalin (methylphenidate)
    +
    indapamide
    1 interaction

    Monitor/Modify Tx

    methylphenidate + indapamide

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • indomethacin
  • Ritalin (methylphenidate)
    +
    indomethacin
    1 interaction

    Monitor/Modify Tx

    methylphenidate + indomethacin

    monitor BP: combo may incr. risk of HTN (additive effects)

  • irbesartan
  • Ritalin (methylphenidate)
    +
    irbesartan
    1 interaction

    Monitor/Modify Tx

    methylphenidate + irbesartan

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • isoflurane
  • Ritalin (methylphenidate)
    +
    isoflurane
    1 interaction

    Monitor/Modify Tx

    methylphenidate + isoflurane

    D/C methylphenidate day of surgery: combo may incr. risk of intraoperative HTN, tachycardia (mechanism unknown)

  • isoproterenol
  • Ritalin (methylphenidate)
    +
    isoproterenol
    1 interaction

    Monitor/Modify Tx

    methylphenidate + isoproterenol

    monitor HR: combo may incr. risk of tachycardia (additive effects)

  • isradipine
  • Ritalin (methylphenidate)
    +
    isradipine
    1 interaction

    Monitor/Modify Tx

    methylphenidate + isradipine

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • ketamine
  • Ritalin (methylphenidate)
    +
    ketamine
    1 interaction

    Monitor/Modify Tx

    methylphenidate + ketamine

    monitor BP, HR: combo may incr. risk of HTN, tachycardia, other sympathomimetic adverse effects (additive effects)

  • ketoprofen
  • Ritalin (methylphenidate)
    +
    ketoprofen
    1 interaction

    Monitor/Modify Tx

    methylphenidate + ketoprofen

    monitor BP: combo may incr. risk of HTN (additive effects)

  • ketorolac
  • Ritalin (methylphenidate)
    +
    ketorolac
    1 interaction

    Monitor/Modify Tx

    methylphenidate + ketorolac

    monitor BP: combo may incr. risk of HTN (additive effects)

  • labetalol
  • Ritalin (methylphenidate)
    +
    labetalol
    1 interaction

    Monitor/Modify Tx

    methylphenidate + labetalol

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • lanreotide
  • Ritalin (methylphenidate)
    +
    lanreotide
    1 interaction

    Monitor/Modify Tx

    methylphenidate + lanreotide

    monitor BP: combo may incr. risk of HTN (additive effects)

  • leflunomide
  • Ritalin (methylphenidate)
    +
    leflunomide
    1 interaction

    Monitor/Modify Tx

    methylphenidate + leflunomide

    monitor BP: combo may incr. risk of HTN (additive effects)

  • lenvatinib
  • Ritalin (methylphenidate)
    +
    lenvatinib
    1 interaction

    Monitor/Modify Tx

    methylphenidate + lenvatinib

    monitor BP: combo may incr. risk of HTN (additive effects)

  • levalbuterol inhaled
  • Ritalin (methylphenidate)
    +
    levalbuterol inhaled
    1 interaction

    Monitor/Modify Tx

    methylphenidate + levalbuterol inhaled

    monitor BP, HR: combo may incr. risk of HTN, tachycardia, other cardiovascular adverse effects (additive effects)

  • levothyroxine
  • Ritalin (methylphenidate)
    +
    levothyroxine
    1 interaction

    Monitor/Modify Tx

    methylphenidate + levothyroxine

    monitor BP, HR: combo may incr. risk of HTN, tachycardia (additive effects)

  • licorice
  • Ritalin (methylphenidate)
    +
    licorice
    1 interaction

    Monitor/Modify Tx

    methylphenidate + licorice

    monitor BP w/ large amounts of licorice: combo may incr. risk of HTN (additive effects)

  • lifileucel
  • Ritalin (methylphenidate)
    +
    lifileucel
    1 interaction

    Monitor/Modify Tx

    methylphenidate + lifileucel

    monitor HR: combo may incr. risk of tachycardia (additive effects)

  • liothyronine
  • Ritalin (methylphenidate)
    +
    liothyronine
    1 interaction

    Monitor/Modify Tx

    methylphenidate + liothyronine

    monitor BP, HR: combo may incr. risk of HTN, tachycardia (additive effects)

  • liraglutide
  • Ritalin (methylphenidate)
    +
    liraglutide
    1 interaction

    Monitor/Modify Tx

    methylphenidate + liraglutide

    monitor HR: combo may incr. risk of tachycardia (additive effects)

  • lisinopril
  • Ritalin (methylphenidate)
    +
    lisinopril
    1 interaction

    Monitor/Modify Tx

    methylphenidate + lisinopril

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • lorlatinib
  • Ritalin (methylphenidate)
    +
    lorlatinib
    1 interaction

    Monitor/Modify Tx

    methylphenidate + lorlatinib

    monitor BP: combo may incr. risk of HTN (additive effects)

  • losartan
  • Ritalin (methylphenidate)
    +
    losartan
    1 interaction

    Monitor/Modify Tx

    methylphenidate + losartan

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • lumacaftor/ivacaftor
  • Ritalin (methylphenidate)
    +
    lumacaftor/ ivacaftor
    1 interaction

    Monitor/Modify Tx

    methylphenidate + lumacaftor/ ivacaftor

    monitor BP: combo may incr. risk of HTN (additive effects)

  • lumateperone
  • Ritalin (methylphenidate)
    +
    lumateperone
    1 interaction

    Monitor/Modify Tx

    methylphenidate + lumateperone

    monitor serotonin syndrome symptoms, especially during initiation/titration: combo may incr. risk of serotonin syndrome (additive effects)

  • luspatercept
  • Ritalin (methylphenidate)
    +
    luspatercept
    1 interaction

    Monitor/Modify Tx

    methylphenidate + luspatercept

    monitor BP: combo may incr. risk of HTN (additive effects)

  • magnesium salicylate
  • Ritalin (methylphenidate)
    +
    magnesium salicylate
    1 interaction

    Monitor/Modify Tx

    methylphenidate + magnesium salicylate

    monitor BP w/ high-dose magnesium salicylate: combo may incr. risk of HTN (additive effects)

  • meclofenamate
  • Ritalin (methylphenidate)
    +
    meclofenamate
    1 interaction

    Monitor/Modify Tx

    methylphenidate + meclofenamate

    monitor BP: combo may incr. risk of HTN (additive effects)

  • mefenamic acid
  • Ritalin (methylphenidate)
    +
    mefenamic acid
    1 interaction

    Monitor/Modify Tx

    methylphenidate + mefenamic acid

    monitor BP: combo may incr. risk of HTN (additive effects)

  • meloxicam
  • Ritalin (methylphenidate)
    +
    meloxicam
    1 interaction

    Monitor/Modify Tx

    methylphenidate + meloxicam

    monitor BP: combo may incr. risk of HTN (additive effects)

  • methoxy polyethylene glycol-epoetin beta
  • Ritalin (methylphenidate)
    +
    methoxy polyethylene glycol-epoetin beta
    1 interaction

    Monitor/Modify Tx

    methylphenidate + methoxy polyethylene glycol-epoetin beta

    monitor BP: combo may incr. risk of HTN (additive effects)

  • methscopolamine
  • Ritalin (methylphenidate)
    +
    methscopolamine
    1 interaction

    Monitor/Modify Tx

    methylphenidate + methscopolamine

    monitor HR: combo may incr. risk of tachycardia (additive effects)

  • methyldopa
  • Ritalin (methylphenidate)
    +
    methyldopa
    1 interaction

    Monitor/Modify Tx

    methylphenidate + methyldopa

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • methylergonovine
  • Ritalin (methylphenidate)
    +
    methylergonovine
    1 interaction

    Monitor/Modify Tx

    methylphenidate + methylergonovine

    monitor BP, serotonin syndrome sx, especially during initiation/titration: combo may incr. risk of severe HTN, vasospasm, ischemia, serotonin syndrome (additive effects)

  • methylprednisolone
  • Ritalin (methylphenidate)
    +
    methylprednisolone
    1 interaction

    Monitor/Modify Tx

    methylphenidate + methylprednisolone

    monitor BP: combo may incr. risk of HTN (additive effects)

  • methyltestosterone
  • Ritalin (methylphenidate)
    +
    methyltestosterone
    1 interaction

    Monitor/Modify Tx

    methylphenidate + methyltestosterone

    monitor BP: combo may incr. risk of HTN (additive effects)

  • metoclopramide
  • Ritalin (methylphenidate)
    +
    metoclopramide
    1 interaction

    Monitor/Modify Tx

    methylphenidate + metoclopramide

    monitor BP, serotonin syndrome symptoms, especially during initiation/titration: combo may incr. risk of serotonin syndrome, HTN (additive effects)

  • metolazone
  • Ritalin (methylphenidate)
    +
    metolazone
    1 interaction

    Monitor/Modify Tx

    methylphenidate + metolazone

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • metoprolol
  • Ritalin (methylphenidate)
    +
    metoprolol
    1 interaction

    Monitor/Modify Tx

    methylphenidate + metoprolol

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • minoxidil
  • Ritalin (methylphenidate)
    +
    minoxidil
    1 interaction

    Monitor/Modify Tx

    methylphenidate + minoxidil

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • mirabegron
  • Ritalin (methylphenidate)
    +
    mirabegron
    1 interaction

    Monitor/Modify Tx

    methylphenidate + mirabegron

    monitor BP: combo may incr. risk of HTN (additive effects)

  • modafinil
  • Ritalin (methylphenidate)
    +
    modafinil
    1 interaction

    Monitor/Modify Tx

    methylphenidate + modafinil

    monitor BP, HR: combo may incr. risk of HTN, tachycardia (additive effects)

  • moexipril
  • Ritalin (methylphenidate)
    +
    moexipril
    1 interaction

    Monitor/Modify Tx

    methylphenidate + moexipril

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • nabumetone
  • Ritalin (methylphenidate)
    +
    nabumetone
    1 interaction

    Monitor/Modify Tx

    methylphenidate + nabumetone

    monitor BP: combo may incr. risk of HTN (additive effects)

  • nadolol
  • Ritalin (methylphenidate)
    +
    nadolol
    1 interaction

    Monitor/Modify Tx

    methylphenidate + nadolol

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • naproxen
  • Ritalin (methylphenidate)
    +
    naproxen
    1 interaction

    Monitor/Modify Tx

    methylphenidate + naproxen

    monitor BP: combo may incr. risk of HTN (additive effects)

  • naratriptan
  • Ritalin (methylphenidate)
    +
    naratriptan
    1 interaction

    Monitor/Modify Tx

    methylphenidate + naratriptan

    monitor BP, serotonin syndrome sx, especially during initiation/titration: combo may incr. risk of HTN, serotonin syndrome (additive effects)

  • naxitamab
  • Ritalin (methylphenidate)
    +
    naxitamab
    1 interaction

    Monitor/Modify Tx

    methylphenidate + naxitamab

    monitor BP: combo may incr. risk of HTN (additive effects)

  • nebivolol
  • Ritalin (methylphenidate)
    +
    nebivolol
    1 interaction

    Monitor/Modify Tx

    methylphenidate + nebivolol

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • nefazodone
  • Ritalin (methylphenidate)
    +
    nefazodone
    1 interaction

    Monitor/Modify Tx

    methylphenidate + nefazodone

    monitor serotonin syndrome symptoms, especially during initiation/titration: combo may incr. risk of serotonin syndrome (additive effects)

  • nicardipine
  • Ritalin (methylphenidate)
    +
    nicardipine
    1 interaction

    Monitor/Modify Tx

    methylphenidate + nicardipine

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • nicotine
  • Ritalin (methylphenidate)
    +
    nicotine
    1 interaction

    Monitor/Modify Tx

    methylphenidate + nicotine

    monitor BP, HR: combo may incr. risk of HTN, tachycardia (additive effects)

  • nifedipine
  • Ritalin (methylphenidate)
    +
    nifedipine
    1 interaction

    Monitor/Modify Tx

    methylphenidate + nifedipine

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • nimodipine
  • Ritalin (methylphenidate)
    +
    nimodipine
    1 interaction

    Monitor/Modify Tx

    methylphenidate + nimodipine

    monitor BP: combo may decr. nimodipine efficacy (antagonistic effects)

  • niraparib
  • Ritalin (methylphenidate)
    +
    niraparib
    1 interaction

    Monitor/Modify Tx

    methylphenidate + niraparib

    monitor BP: combo may incr. risk of HTN (additive effects)

  • nisoldipine
  • Ritalin (methylphenidate)
    +
    nisoldipine
    1 interaction

    Monitor/Modify Tx

    methylphenidate + nisoldipine

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • norepinephrine
  • Ritalin (methylphenidate)
    +
    norepinephrine
    1 interaction

    Monitor/Modify Tx

    methylphenidate + norepinephrine

    monitor BP: combo may incr. risk of severe HTN (additive effects)

  • obinutuzumab
  • Ritalin (methylphenidate)
    +
    obinutuzumab
    1 interaction

    Monitor/Modify Tx

    methylphenidate + obinutuzumab

    monitor BP: combo may incr. risk of HTN, including hypertensive crisis (additive effects)

  • olmesartan medoxomil
  • Ritalin (methylphenidate)
    +
    olmesartan medoxomil
    1 interaction

    Monitor/Modify Tx

    methylphenidate + olmesartan medoxomil

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • olodaterol inhaled
  • Ritalin (methylphenidate)
    +
    olodaterol inhaled
    1 interaction

    Monitor/Modify Tx

    methylphenidate + olodaterol inhaled

    monitor BP, HR: combo may incr. risk of HTN, tachycardia, other cardiovascular adverse effects (additive effects)

  • orphenadrine
  • Ritalin (methylphenidate)
    +
    orphenadrine
    1 interaction

    Monitor/Modify Tx

    methylphenidate + orphenadrine

    monitor HR: combo may incr. risk of tachycardia (additive effects)

  • osilodrostat
  • Ritalin (methylphenidate)
    +
    osilodrostat
    1 interaction

    Monitor/Modify Tx

    methylphenidate + osilodrostat

    monitor BP: combo may incr. risk of HTN (additive effects)

  • oxaprozin
  • Ritalin (methylphenidate)
    +
    oxaprozin
    1 interaction

    Monitor/Modify Tx

    methylphenidate + oxaprozin

    monitor BP: combo may incr. risk of HTN (additive effects)

  • oxymetazoline nasal
  • Ritalin (methylphenidate)
    +
    oxymetazoline nasal
    1 interaction

    Monitor/Modify Tx

    methylphenidate + oxymetazoline nasal

    monitor BP: combo may incr. risk of HTN (additive effects)

  • oxytocin
  • Ritalin (methylphenidate)
    +
    oxytocin
    1 interaction

    Monitor/Modify Tx

    methylphenidate + oxytocin

    monitor BP: combo may incr. risk of HTN, including life-threatening (additive effects)

  • ozanimod
  • Ritalin (methylphenidate)
    +
    ozanimod
    1 interaction

    Monitor/Modify Tx

    methylphenidate + ozanimod

    monitor BP: combo may incr. risk of HTN, including hypertensive crisis (additive effects)

  • palonosetron
  • Ritalin (methylphenidate)
    +
    palonosetron
    1 interaction

    Monitor/Modify Tx

    methylphenidate + palonosetron

    monitor serotonin syndrome sx, especially during initiation/titration: combo may incr. risk of serotonin syndrome (additive effects)

  • pazopanib
  • Ritalin (methylphenidate)
    +
    pazopanib
    1 interaction

    Monitor/Modify Tx

    methylphenidate + pazopanib

    monitor BP: combo may incr. risk of HTN (additive effects)

  • perindopril
  • Ritalin (methylphenidate)
    +
    perindopril
    1 interaction

    Monitor/Modify Tx

    methylphenidate + perindopril

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • pexidartinib
  • Ritalin (methylphenidate)
    +
    pexidartinib
    1 interaction

    Monitor/Modify Tx

    methylphenidate + pexidartinib

    monitor BP: combo may incr. risk of HTN (additive effects)

  • phenoxybenzamine
  • Ritalin (methylphenidate)
    +
    phenoxybenzamine
    1 interaction

    Monitor/Modify Tx

    methylphenidate + phenoxybenzamine

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • phentermine
  • Ritalin (methylphenidate)
    +
    phentermine
    1 interaction

    Monitor/Modify Tx

    methylphenidate + phentermine

    monitor BP, HR: combo may incr. risk of HTN, tachycardia, CNS stimulatory effects (additive effects)

  • phentolamine
  • Ritalin (methylphenidate)
    +
    phentolamine
    1 interaction

    Monitor/Modify Tx

    methylphenidate + phentolamine

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • phenylephrine
  • Ritalin (methylphenidate)
    +
    phenylephrine
    1 interaction

    Monitor/Modify Tx

    methylphenidate + phenylephrine

    monitor BP, HR: combo may incr. risk of HTN, tachycardia, other cardiovascular and CNS stimulatory effects (additive effects)

  • phenylephrine injection
  • Ritalin (methylphenidate)
    +
    phenylephrine injection
    1 interaction

    Monitor/Modify Tx

    methylphenidate + phenylephrine injection

    monitor BP: combo may incr. risk of HTN (additive effects)

  • phenylephrine nasal
  • Ritalin (methylphenidate)
    +
    phenylephrine nasal
    1 interaction

    Monitor/Modify Tx

    methylphenidate + phenylephrine nasal

    monitor BP: combo may incr. risk of HTN, other cardiovascular and CNS stimulatory effects (additive effects)

  • phenylephrine ophthalmic
  • Ritalin (methylphenidate)
    +
    phenylephrine ophthalmic
    1 interaction

    Monitor/Modify Tx

    methylphenidate + phenylephrine ophthalmic

    monitor BP, HR; risk may be lower w/ phenylephrine ophthalmic 2.5%: combo may incr. risk of HTN, tachycardia (additive effects)

  • phenylephrine rectal
  • Ritalin (methylphenidate)
    +
    phenylephrine rectal
    1 interaction

    Monitor/Modify Tx

    methylphenidate + phenylephrine rectal

    monitor BP: combo may incr. risk of HTN, other cardiovascular and CNS stimulatory effects (additive effects)

  • phenytoin
  • Ritalin (methylphenidate)
    +
    phenytoin
    1 interaction

    Monitor/Modify Tx

    methylphenidate + phenytoin

    monitor phenytoin levels: combo may incr. phenytoin levels, risk of toxicity (mechanism unknown, hepatic metabolism possibly inhibited)

  • pindolol
  • Ritalin (methylphenidate)
    +
    pindolol
    1 interaction

    Monitor/Modify Tx

    methylphenidate + pindolol

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • piroxicam
  • Ritalin (methylphenidate)
    +
    piroxicam
    1 interaction

    Monitor/Modify Tx

    methylphenidate + piroxicam

    monitor BP: combo may incr. risk of HTN (additive effects)

  • ponatinib
  • Ritalin (methylphenidate)
    +
    ponatinib
    1 interaction

    Monitor/Modify Tx

    methylphenidate + ponatinib

    monitor BP: combo may incr. risk of HTN (additive effects)

  • ponesimod
  • Ritalin (methylphenidate)
    +
    ponesimod
    1 interaction

    Monitor/Modify Tx

    methylphenidate + ponesimod

    monitor BP: combo may incr. risk of HTN (additive effects)

  • pralsetinib
  • Ritalin (methylphenidate)
    +
    pralsetinib
    1 interaction

    Monitor/Modify Tx

    methylphenidate + pralsetinib

    monitor BP: combo may incr. risk of HTN (additive effects)

  • prazosin
  • Ritalin (methylphenidate)
    +
    prazosin
    1 interaction

    Monitor/Modify Tx

    methylphenidate + prazosin

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • prednisolone
  • Ritalin (methylphenidate)
    +
    prednisolone
    1 interaction

    Monitor/Modify Tx

    methylphenidate + prednisolone

    monitor BP: combo may incr. risk of HTN (additive effects)

  • prednisone
  • Ritalin (methylphenidate)
    +
    prednisone
    1 interaction

    Monitor/Modify Tx

    methylphenidate + prednisone

    monitor BP: combo may incr. risk of HTN (additive effects)

  • propranolol
  • Ritalin (methylphenidate)
    +
    propranolol
    1 interaction

    Monitor/Modify Tx

    methylphenidate + propranolol

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • protriptyline
  • Ritalin (methylphenidate)
    +
    protriptyline
    1 interaction

    Monitor/Modify Tx

    methylphenidate + protriptyline

    monitor BP, HR, serotonin syndrome symptoms, especially during initiation/titration: combo may incr. risk of HTN, tachycardia, serotonin syndrome (additive effects)

  • pseudoephedrine
  • Ritalin (methylphenidate)
    +
    pseudoephedrine
    1 interaction

    Monitor/Modify Tx

    methylphenidate + pseudoephedrine

    monitor BP, HR: combo may incr. risk of HTN, tachycardia, CNS stimulatory effects (additive effects)

  • quetiapine
  • Ritalin (methylphenidate)
    +
    quetiapine
    1 interaction

    Monitor/Modify Tx

    methylphenidate + quetiapine

    monitor BP, especially in patients <18 yo: combo may incr. risk of HTN (additive effects)

  • quinapril
  • Ritalin (methylphenidate)
    +
    quinapril
    1 interaction

    Monitor/Modify Tx

    methylphenidate + quinapril

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • ramipril
  • Ritalin (methylphenidate)
    +
    ramipril
    1 interaction

    Monitor/Modify Tx

    methylphenidate + ramipril

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • ramucirumab
  • Ritalin (methylphenidate)
    +
    ramucirumab
    1 interaction

    Monitor/Modify Tx

    methylphenidate + ramucirumab

    monitor BP: combo may incr. risk of HTN (additive effects)

  • regorafenib
  • Ritalin (methylphenidate)
    +
    regorafenib
    1 interaction

    Monitor/Modify Tx

    methylphenidate + regorafenib

    monitor BP: combo may incr. risk of HTN (additive effects)

  • rimegepant
  • Ritalin (methylphenidate)
    +
    rimegepant
    1 interaction

    Monitor/Modify Tx

    methylphenidate + rimegepant

    monitor BP: combo may incr. risk of HTN (additive effects)

  • ripretinib
  • Ritalin (methylphenidate)
    +
    ripretinib
    1 interaction

    Monitor/Modify Tx

    methylphenidate + ripretinib

    monitor BP: combo may incr. risk of HTN (additive effects)

  • rizatriptan
  • Ritalin (methylphenidate)
    +
    rizatriptan
    1 interaction

    Monitor/Modify Tx

    methylphenidate + rizatriptan

    monitor BP, serotonin syndrome sx, especially during initiation/titration: combo may incr. risk of HTN, serotonin syndrome (additive effects)

  • ropinirole
  • Ritalin (methylphenidate)
    +
    ropinirole
    1 interaction

    Monitor/Modify Tx

    methylphenidate + ropinirole

    monitor BP: combo may incr. risk of HTN (additive effects)

  • rotigotine transdermal
  • Ritalin (methylphenidate)
    +
    rotigotine transdermal
    1 interaction

    Monitor/Modify Tx

    methylphenidate + rotigotine transdermal

    monitor BP, HR: combo may incr. risk of HTN, tachycardia (additive effects)

  • salmeterol inhaled
  • Ritalin (methylphenidate)
    +
    salmeterol inhaled
    1 interaction

    Monitor/Modify Tx

    methylphenidate + salmeterol inhaled

    monitor BP, HR: combo may incr. risk of HTN, tachycardia, other cardiovascular adverse effects (additive effects)

  • salsalate
  • Ritalin (methylphenidate)
    +
    salsalate
    1 interaction

    Monitor/Modify Tx

    methylphenidate + salsalate

    monitor BP w/ high-dose salsalate: combo may incr. risk of HTN (additive effects)

  • SAMe
  • Ritalin (methylphenidate)
    +
    SAMe
    1 interaction

    Monitor/Modify Tx

    methylphenidate + SAMe

    monitor serotonin syndrome sx, especially during initiation/titration: combo may incr. risk of serotonin syndrome (additive effects)

  • selpercatinib
  • Ritalin (methylphenidate)
    +
    selpercatinib
    1 interaction

    Monitor/Modify Tx

    methylphenidate + selpercatinib

    monitor BP: combo may incr. risk of HTN (additive effects)

  • sevoflurane
  • Ritalin (methylphenidate)
    +
    sevoflurane
    1 interaction

    Monitor/Modify Tx

    methylphenidate + sevoflurane

    D/C methylphenidate day of surgery: combo may incr. risk of intraoperative HTN, tachycardia (mechanism unknown)

  • siponimod
  • Ritalin (methylphenidate)
    +
    siponimod
    1 interaction

    Monitor/Modify Tx

    methylphenidate + siponimod

    monitor BP: combo may incr. risk of HTN (additive effects)

  • solriamfetol
  • Ritalin (methylphenidate)
    +
    solriamfetol
    1 interaction

    Monitor/Modify Tx

    methylphenidate + solriamfetol

    monitor BP, HR: combo may incr. risk of HTN, tachycardia (additive effects)

  • sorafenib
  • Ritalin (methylphenidate)
    +
    sorafenib
    1 interaction

    Monitor/Modify Tx

    methylphenidate + sorafenib

    monitor BP: combo may incr. risk of HTN (additive effects)

  • spironolactone
  • Ritalin (methylphenidate)
    +
    spironolactone
    1 interaction

    Monitor/Modify Tx

    methylphenidate + spironolactone

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • St. John's wort
  • Ritalin (methylphenidate)
    +
    St. John's wort
    1 interaction

    Monitor/Modify Tx

    methylphenidate + St. John's wort

    monitor serotonin syndrome sx, especially during initiation/titration: combo may incr. risk of serotonin syndrome; may decr. methylphenidate efficacy (additive effects; mechanism unknown)

  • sulindac
  • Ritalin (methylphenidate)
    +
    sulindac
    1 interaction

    Monitor/Modify Tx

    methylphenidate + sulindac

    monitor BP: combo may incr. risk of HTN (additive effects)

  • sumatriptan
  • Ritalin (methylphenidate)
    +
    sumatriptan
    1 interaction

    Monitor/Modify Tx

    methylphenidate + sumatriptan

    monitor BP, serotonin syndrome symptoms, especially during initiation/titration: combo may incr. risk of HTN, serotonin syndrome (additive effects)

  • sunitinib
  • Ritalin (methylphenidate)
    +
    sunitinib
    1 interaction

    Monitor/Modify Tx

    methylphenidate + sunitinib

    monitor BP: combo may incr. risk of HTN (additive effects)

  • tacrolimus
  • Ritalin (methylphenidate)
    +
    tacrolimus
    1 interaction

    Monitor/Modify Tx

    methylphenidate + tacrolimus

    monitor BP: combo may incr. risk of HTN (additive effects)

  • tagraxofusp
  • Ritalin (methylphenidate)
    +
    tagraxofusp
    1 interaction

    Monitor/Modify Tx

    methylphenidate + tagraxofusp

    monitor BP: combo may incr. risk of HTN (additive effects)

  • telmisartan
  • Ritalin (methylphenidate)
    +
    telmisartan
    1 interaction

    Monitor/Modify Tx

    methylphenidate + telmisartan

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • terazosin
  • Ritalin (methylphenidate)
    +
    terazosin
    1 interaction

    Monitor/Modify Tx

    methylphenidate + terazosin

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • terbutaline
  • Ritalin (methylphenidate)
    +
    terbutaline
    1 interaction

    Monitor/Modify Tx

    methylphenidate + terbutaline

    monitor BP, HR: combo may incr. risk of HTN, tachycardia, other cardiovascular adverse effects (additive effects)

  • teriflunomide
  • Ritalin (methylphenidate)
    +
    teriflunomide
    1 interaction

    Monitor/Modify Tx

    methylphenidate + teriflunomide

    monitor BP: combo may incr. risk of HTN (additive effects)

  • testosterone
  • Ritalin (methylphenidate)
    +
    testosterone
    1 interaction

    Monitor/Modify Tx

    methylphenidate + testosterone

    monitor BP: combo may incr. risk of HTN (additive effects)

  • thyroid
  • Ritalin (methylphenidate)
    +
    thyroid
    1 interaction

    Monitor/Modify Tx

    methylphenidate + thyroid

    monitor BP, HR: combo may incr. risk of HTN, tachycardia (additive effects)

  • timolol
  • Ritalin (methylphenidate)
    +
    timolol
    1 interaction

    Monitor/Modify Tx

    methylphenidate + timolol

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • tivozanib
  • Ritalin (methylphenidate)
    +
    tivozanib
    1 interaction

    Monitor/Modify Tx

    methylphenidate + tivozanib

    monitor BP: combo may incr. risk of HTN, including hypertensive crisis (additive effects)

  • tolmetin
  • Ritalin (methylphenidate)
    +
    tolmetin
    1 interaction

    Monitor/Modify Tx

    methylphenidate + tolmetin

    monitor BP: combo may incr. risk of HTN (additive effects)

  • torsemide
  • Ritalin (methylphenidate)
    +
    torsemide
    1 interaction

    Monitor/Modify Tx

    methylphenidate + torsemide

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • trametinib
  • Ritalin (methylphenidate)
    +
    trametinib
    1 interaction

    Monitor/Modify Tx

    methylphenidate + trametinib

    monitor BP: combo may incr. risk of HTN (additive effects)

  • trandolapril
  • Ritalin (methylphenidate)
    +
    trandolapril
    1 interaction

    Monitor/Modify Tx

    methylphenidate + trandolapril

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • trazodone
  • Ritalin (methylphenidate)
    +
    trazodone
    1 interaction

    Monitor/Modify Tx

    methylphenidate + trazodone

    monitor serotonin syndrome sx, especially during initiation/titration: combo may incr. risk of serotonin syndrome (additive effects)

  • triamcinolone
  • Ritalin (methylphenidate)
    +
    triamcinolone
    1 interaction

    Monitor/Modify Tx

    methylphenidate + triamcinolone

    monitor BP: combo may incr. risk of HTN (additive effects)

  • triamterene
  • Ritalin (methylphenidate)
    +
    triamterene
    1 interaction

    Monitor/Modify Tx

    methylphenidate + triamterene

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • trospium
  • Ritalin (methylphenidate)
    +
    trospium
    1 interaction

    Monitor/Modify Tx

    methylphenidate + trospium

    monitor HR: combo may incr. risk of tachycardia (additive effects)

  • ubrogepant
  • Ritalin (methylphenidate)
    +
    ubrogepant
    1 interaction

    Monitor/Modify Tx

    methylphenidate + ubrogepant

    monitor BP: combo may incr. risk of HTN (additive effects)

  • vadadustat
  • Ritalin (methylphenidate)
    +
    vadadustat
    1 interaction

    Monitor/Modify Tx

    methylphenidate + vadadustat

    monitor BP: combo may incr. risk of HTN, including hypertensive crisis (additive effects)

  • valsartan
  • Ritalin (methylphenidate)
    +
    valsartan
    1 interaction

    Monitor/Modify Tx

    methylphenidate + valsartan

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • vamorolone
  • Ritalin (methylphenidate)
    +
    vamorolone
    1 interaction

    Monitor/Modify Tx

    methylphenidate + vamorolone

    monitor BP: combo may incr. risk of HTN (additive effects)

  • vandetanib
  • Ritalin (methylphenidate)
    +
    vandetanib
    1 interaction

    Monitor/Modify Tx

    methylphenidate + vandetanib

    monitor BP: combo may incr. risk of HTN (additive effects)

  • vasopressin
  • Ritalin (methylphenidate)
    +
    vasopressin
    1 interaction

    Monitor/Modify Tx

    methylphenidate + vasopressin

    monitor BP: combo may incr. risk of HTN (additive effects)

  • verapamil
  • Ritalin (methylphenidate)
    +
    verapamil
    1 interaction

    Monitor/Modify Tx

    methylphenidate + verapamil

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • vilanterol inhaled
  • Ritalin (methylphenidate)
    +
    vilanterol inhaled
    1 interaction

    Monitor/Modify Tx

    methylphenidate + vilanterol inhaled

    monitor BP, HR: combo may incr. risk of HTN, tachycardia, other cardiovascular adverse effects (additive effects)

  • viloxazine
  • Ritalin (methylphenidate)
    +
    viloxazine
    1 interaction

    Monitor/Modify Tx

    methylphenidate + viloxazine

    monitor BP, HR: combo may incr. risk of HTN, tachycardia (additive effects)

  • voclosporin
  • Ritalin (methylphenidate)
    +
    voclosporin
    1 interaction

    Monitor/Modify Tx

    methylphenidate + voclosporin

    monitor BP: combo may incr. risk of HTN (additive effects)

  • zavegepant
  • Ritalin (methylphenidate)
    +
    zavegepant
    1 interaction

    Monitor/Modify Tx

    methylphenidate + zavegepant

    monitor BP: combo may incr. risk of HTN (additive effects)

  • ziv-aflibercept
  • Ritalin (methylphenidate)
    +
    ziv-aflibercept
    1 interaction

    Monitor/Modify Tx

    methylphenidate + ziv-aflibercept

    monitor BP: combo may incr. risk of HTN (additive effects)

  • zolmitriptan
  • Ritalin (methylphenidate)
    +
    zolmitriptan
    1 interaction

    Monitor/Modify Tx

    methylphenidate + zolmitriptan

    monitor BP, serotonin syndrome sx, especially during initiation/titration: combo may incr. risk of HTN, serotonin syndrome (additive effects)

Caution Advised

  • ginseng, Asian
  • Ritalin (methylphenidate)
    +
    ginseng, Asian
    1 interaction

    Caution Advised

    methylphenidate + ginseng, Asian

    caution advised: combo may potentiate stimulant effects (mechanism unknown, Panax ginseng may alter CNS neurotransmitters)

  • risperidone
  • Ritalin (methylphenidate)
    +
    risperidone
    1 interaction

    Caution Advised

    methylphenidate + risperidone

    caution advised, especially during initiation/titration or D/C: combo may incr. risk of extrapyramidal symptoms (mechanism unknown)

Adverse Reactions .

Serious Reactions

    com.epocrates.rxweb.beans.StringCollection@65540eb3
  • dependency
  • abuse
  • psychosis
  • mania
  • aggressive behavior
  • HTN
  • MI
  • stroke
  • arrhythmia
  • sudden death (patients with severe cardiac disease)
  • seizures
  • hypersensitivity reaction
  • angioedema
  • anaphylaxis
  • exfoliative dermatitis
  • erythema multiforme
  • thrombocytopenic purpura
  • blood dyscrasia
  • priapism
  • peripheral vasculopathy
  • Raynaud phenomenon
  • growth suppression (long-term use in peds patients)
  • weight loss (ER form use in peds patients)
  • glaucoma
  • rhabdomyolysis
  • hepatotoxicity
  • withdrawal symptoms if abrupt D/C (prolonged use)

Common Reactions

    com.epocrates.rxweb.beans.StringCollection@6306a3f0
  • anorexia
  • headache
  • xerostomia
  • nausea
  • insomnia
  • anxiety
  • abdominal pain
  • dizziness
  • weight loss
  • irritability
  • hyperhidrosis
  • fever
  • tachycardia
  • vomiting
  • nervousness
  • palpitations
  • restlessness
  • URI
  • tremor
  • dyspepsia
  • BP incr.
  • HR incr.
  • visual disturbance
  • affect lability
  • tics

Safety/Monitoring .

Monitoring Parameters
cardiac evaluation at baseline; BP, HR; height, weight in peds at baseline, then periodically; ophthalmic exam if glaucoma risk; consider CBC with diff, Plt if prolonged tx

Look/Sound-Alike Drug Names
Ritalin confused with: Ritalin SR


methylphenidate confused with: methadone; methamphetamine

Pregnancy/Lactation .

Pregnancy

Clinical Summary

weigh risk/benefit during pregnancy; no known risk of teratogenicity based on limited human data; possible risk of vasoconstriction in pregnant patients and decr. placental perfusion based on drug's mechanism of action

Pregnancy Registry

encourage patients to enroll in National Pregnancy Registry for ADHD Medications at 1-866-961-2388 or www.womensmentalhealth.org/adhd-medications

Lactation

Clinical Summary

weigh risk/benefit while breastfeeding; no known risk of infant harm based on limited human data; no human data available, though theoretical decr. milk production based on decr. prolactin levels

Pharmacology .

com.epocrates.rxweb.beans.DrugOtherInfoBean@1d4d2ee

Metabolism: for methylphenidate: de-esterification primarily; CYP450: none

Excretion: for methylphenidate: urine 78-97% (<1% unchanged), feces 1-3%; Half-life: 3.5h (IR tabs, adults), 2.5h (IR tabs, peds), 2.7h (IR solution, adults), 2.4-6.8h (ER forms)

Subclass: Attention Deficit Hyperactivity Disorder (ADHD) ; Narcolepsy/Somnolence ; Norepinephrine-Dopamine Reuptake Inhibitors (NDRIs)

Mechanism of Action
for methylphenidate: exact mechanism of action unknown; stimulates CNS activity; blocks reuptake and increases release of norepinephrine and dopamine in extraneuronal space (sympathomimetic)

Formulary .

No Formulary Selected

Manufacturer/Pricing .

Manufacturer: Novartis Pharmaceuticals Corp.

com.epocrates.rxweb.beans.DrugOtherInfoBean@3c5d5bd2

DEA/FDA: Schedule II

Retail Price

Estimated prices only. For current pricing, visit GoodRx.

oral tablet:

  • 5 mg (90 ea): $66.00
  • 10 mg (90 ea): $92.00
  • 20 mg (60 ea): $89.00

Join Now to View Patient Handouts!

Create a FREE epocrates Online account to access patient medication instructions. Your patients and caregivers will appreciate you printing these friendly handouts, available in English and Spanish. Each handout addresses common concerns such as how to take the medication, and possible side effects.

Current Members: Sign In.

Sign Up Now - It's Free >>

Pill Pictures

Join Now to View Pill Pictures!

Create a FREE epocrates Online account to access full-color images of medications within the drug monograph.

Current Members: Sign In.

Sign Up Now - It's Free >>

Help
FDA Reporting Form
 
Download Epocrates from the App Store Download Epocrates from the Play Store
About Us Features Business Solutions Help & Feedback
© 2026 epocrates, Inc.    Terms of Use Privacy Policy Editorial Policy Do Not Sell or Share My Information